FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jesús San Miguel

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Co-author Network

Publications

TOP 3
Irena Misiewicz-Krzeminska; Enrique M Ocio; Teresa Paíno; Dalia Quwaider; Jesús F San Miguel; Maria Eugenia Sarasquete; Fany V Ticona; Andreia Aires; Manuel Delgado; Ramón García-Sanz; Patryk Krzeminski; Norma C Gutiérrez
Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication.
P Leif Bergsagel; Norma C Gutierrez; María-Victoria Mateos; S Vincent Rajkumar; Jesús F San Miguel
Improving overall survival and overcoming adverse prognosis in the treatment of cytogenetically high-risk multiple myeloma.
Jesús F San Miguel; Rudolf Schlag; Ofer Shpilberg; Ivan Spicka; Helgi van de Velde; Olga S Samoilova; Kudrat M Abdulkadyrov; Kenneth C Anderson; Andrew Cakana; Michel Delforge; William Deraedt; Meletios A Dimopoulos; Anna Dmoszynska; Dixie-Lee Esseltine; Bin Jiang; Nuriet K Khuageva; Martin Kropff; Kevin Liu; Maria-Victoria Mateos; Antonio Palumbo; Maria Teresa Petrucci; Paul G Richardson
Persistent overall survival benefit and no increased risk of second malignancies with bortezomib-melphalan-prednisone versus melphalan-prednisone in patients with previously untreated multiple myeloma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jesús San Miguel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Irena Misiewicz-Krzeminska; Enrique M Ocio; Teresa Paíno; Dalia Quwaider; Jesús F San Miguel; Maria Eugenia Sarasquete; Fany V Ticona; Andreia Aires; Manuel Delgado; Ramón García-Sanz; Patryk Krzeminski; Norma C Gutiérrez
Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication.
Haematologica 2013;98(4):640-8.
2013: P Leif Bergsagel; Norma C Gutierrez; María-Victoria Mateos; S Vincent Rajkumar; Jesús F San Miguel
Improving overall survival and overcoming adverse prognosis in the treatment of cytogenetically high-risk multiple myeloma.
Blood 2013;121(6):884-92.
2013: Jesús F San Miguel; Rudolf Schlag; Ofer Shpilberg; Ivan Spicka; Helgi van de Velde; Olga S Samoilova; Kudrat M Abdulkadyrov; Kenneth C Anderson; Andrew Cakana; Michel Delforge; William Deraedt; Meletios A Dimopoulos; Anna Dmoszynska; Dixie-Lee Esseltine; Bin Jiang; Nuriet K Khuageva; Martin Kropff; Kevin Liu; Maria-Victoria Mateos; Antonio Palumbo; Maria Teresa Petrucci; Paul G Richardson
Persistent overall survival benefit and no increased risk of second malignancies with bortezomib-melphalan-prednisone versus melphalan-prednisone in patients with previously untreated multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(4):448-55.
2013: Antonio Garcia-Gomez; Enrique M Ocio; Atanasio Pandiella; Jesús F San Miguel; Mercedes Garayoa
RAF265, a dual BRAF and VEGFR2 inhibitor, prevents osteoclast formation and resorption. Therapeutic implications.
Investigational new drugs 2013;31(1):200-5.
2013: Michelle A Hurchla; C J Kirk; A Li; Enrique M Ocio; Atanasio Pandiella; David Piwnica-Worms; Jesús F San Miguel; Zhifu Xiang; R Vij; Juan F Blanco; L Collins; Mercedes Garayoa; A Garcia-Gomez; M C Hornick; Katherine N Weilbaecher
The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects.
Leukemia 2013;27(2):430-40.
2013: Noemí Puig; Jesús F San Miguel; Maria Eugenia Sarasquete; Elena Sebastián; Miguel Alcoceba; Ana Balanzategui; M Carmen Chillón; Marcos González Díaz; Luis A Marín; Ramón García Sanz
The use of CD138 positively selected marrow samples increases the applicability of minimal residual disease assessment by PCR in patients with multiple myeloma.
Annals of hematology 2013;92(1):97-100.
2013: Margarita Blanes; Adrián Alegre; Joan Bladé; José D González; Juan José Lahuerta; Paz Ribas; Jesús F San Miguel; Miguel A Sanz; Carlos Solano; Javier de la Rubia
Intravenous busulfan and melphalan as a conditioning regimen for autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: a matched comparison to a melphalan-only approach.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(1):69-74.
2013: Roberto J Pessoa de Magalhães; Monica Roig; Jesús F San Miguel; María-Belén Vidriales; Juan F Blanco; Elaine Sobral Costa; Javier de la Rubia; Natalia de las Heras; Carlos Fernandez-Gimenez; Ramón García-Sanz; Norma C Gutierrez; Jose Hernández; Juan José Lahuerta; Quentin Lecrevisse; Angelo Maiolino; Joaquin Martinez-Lopez; Maria V Mateos; Marcio Nucci; Enrique M Ocio; Alberto Orfao; Bruno Paiva; Martin Perez-Andres
Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry.
Haematologica 2013;98(1):79-86.
2012: Carlos Santamaría; Guillermo F Sanz; Mar Tormo; Blanca Xicoy; Javier Sánchez del Real; Eva Barragán; CM Chillón; Raquel de Paz; Consuelo del Cañizo; María Diez-Campelo; Ramón García-Sanz; Montserrat Hernández; Andrés Insunza; Carmen Pedro; Noemi Puig; Fernando Ramos; Eduardo Salido; Jesús F San Miguel; Marcos González
Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival.
Annals of hematology 2012;91(12):1887-95.
2012: L López-Corral; Maria V Mateos; A Oriol; Jesús F San Miguel; Maria Eugenia Sarasquete; José María Sayagués; J Hernández; M T Hernández-García; J M Hernández-Rivas; S Beà; J Bladé; L A Corchete; E M García; Ramón García-Sanz; P Giraldo; M González; Norma C Gutiérrez
SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status.
Leukemia 2012;26(12):2521-9.
2012: Elena Sebastián; Miguel Alcoceba; Ana Balanzategui; M Dolores Caballero; M Carmen Chillón; Rocío Corral; Teresa Flores; Ramón García-Sanz; David González; Eva González-Barca; Luis Marín; Alejandro Martín; Santiago Montes-Moreno; Emilia Pardal; Noemí Puig; Jesús F San Miguel; María Eugenia Sarasquete; Marcos González
Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype.
The American journal of pathology 2012;181(5):1879-88.
2012: Bruno Paiva; Luis Palomera; José J Pérez; Laura Rosiñol; Anna Sureda; María José Terol; María-Belén Vídriales; Adrian Alegre; Joan Bladé; Lourdes Cordón; Felipe de Arriba; Javier de la Rubia; Raquel De Paz; Joaquín Díaz-Mediavilla; María-Asunción Echeveste; Ana Gorosquieta; Norma C Gutiérrez; Juan José Lahuerta; Alejandro Martin; Joaquín Martínez-López; María-Victoria Mateos; María-Ángeles Montalbán; Alberto Orfao; Albert Oriol; Jesús F San Miguel
Multiparameter flow cytometry evaluation of plasma cell DNA content and proliferation in 595 transplant-eligible patients with myeloma included in the Spanish GEM2000 and GEM2005<65y trials.
The American journal of pathology 2012;181(5):1870-8.
2012: Noemí Puig; Jesús F San Miguel; María Eugenia Sarasquete; Elena Sebastián; Miguel Alcoceba; Ana Balanzategui; M Carmen Chillón; Marcos G Díaz; Ramón García-Sanz
Kappa deleting element as an alternative molecular target for minimal residual disease assessment by real-time quantitative PCR in patients with multiple myeloma.
European journal of haematology 2012;89(4):328-35.
2012: Maria V Mateos; Albert Oriol; Luis Palomera; Francisco-Javier Peñalver; Montserrat Pérez; Marta Polo; José-María Ribera; Joan Bargay; José-Luis Bello; Enrique Bengoechea; Joan Bladé; Felipe de Arriba; Ramón García-Sanz; Yolanda González; Miquel Granell; Norma C Gutiérrez; Jose-Mariano Hernández; Juan José Lahuerta; Ana López de la Guía; Javier López; Joaquín Martínez-López; María-Luisa Martín-Mateos; Ana-Isabel Teruel; Jesús F San Miguel
Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial.
Blood 2012;120(13):2581-8.
2012: Teresa Caballero-Velázquez; Cristina Calderon; Soraya Carrancio; Consuelo del Cañizo; Silvia Gutierrez-Cosio; Carmen Herrero; Jesús F San Miguel; Luis Ignacio Sánchez-Abarca; Concepción Serrano; Belén Blanco; José A Pérez-Simón
The novel combination of sirolimus and bortezomib prevents graft-versus-host disease but maintains the graft-versus-leukemia effect after allogeneic transplantation.
Haematologica 2012;97(9):1329-37.
2012: Lucía López-Corral; Maria V Mateos; Jesús F San Miguel; María Eugenia Sarasquete; Luis A Corchete; Felipe de Arriba; Javier de la Rubia; Ramón García-Sanz; Juan José Lahuerta; Norma C Gutiérrez
Genomic analysis of high-risk smoldering multiple myeloma.
Haematologica 2012;97(9):1439-43.
2012: Philippe Moreau; Robert Z Orlowski; Antonio Palumbo; Paul G Richardson; Jesús F San Miguel; Michele Cavo; Jean-Luc Harousseau
Proteasome inhibitors in multiple myeloma: 10 years later.
Blood 2012;120(5):947-59.
2012: Enrique M Ocio; Maria-Victoria Mateos; Jesús F San Miguel
Novel agents derived from the currently approved treatments for MM: novel proteasome inhibitors and novel IMIDs.
Expert opinion on investigational drugs 2012;21(8):1075-87.
2012: Carlos Santamaría; María Eugenia Sarasquete; Stela Alvarez-Fernández; Belén Blanco; Soraya Carrancio; Javier De Las Rivas; María Díez-Campelo; Marcos González; Olga López-Villar; Sandra Muntión; Beatriz Rosón; Jesús F San Miguel; Fermín M Sánchez-Guijo; Maria Consuelo Del Cañizo
Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients.
Haematologica 2012;97(8):1218-24.
2012: Jesús F San Miguel
Consolidation therapy in myeloma: a consolidated approach?
Blood 2012;120(1):2-3.
2012: Michel Delforge; Ravinder Dhawan; Dixie Esseltine; Juliette Meunier; Antoine Regnault; Paul G Richardson; Don Robinson; Andrew Cakana; Helgi van de Velde; Jesús F San Miguel
Health-related quality of life in elderly, newly diagnosed multiple myeloma patients treated with VMP vs. MP: results from the VISTA trial.
European journal of haematology 2012;89(1):16-27.
2012: Teresa Paíno; Bruno Paiva; Atanasio Pandiella; Mercedes Garayoa; Norma C Gutiérrez; Enrique M Ocio; Alberto Orfao; Laura San-Segundo; María Eugenia Sarasquete; Jesús F San Miguel
CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype.
Haematologica 2012;97(7):1110-4.
2012: Fermín Sánchez Guijo; Eva M Villarón; Dolores Caballero; María Díez-Campelo; Lucía López-Anglada; Olga López-Villar; Sandra Muntión; Jose A Perez-Simón; Jesús F San Miguel; Maria Consuelo Del Cañizo
Allogeneic mesenchymal stem cell therapy for refractory cytopenias after hematopoietic stem cell transplantation.
Transfusion 2012;52(5):1086-91.
2012: Asher A Chanan-Khan; Sundar Jagannath; Heinz Ludwig; Jesús F San Miguel; Meletios A Dimopoulos
Novel therapeutic agents for the management of patients with multiple myeloma and renal impairment.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(8):2145-63.
2012: Marìa-Victoria Mateos; Jesús F San Miguel
Safety and efficacy of subcutaneous formulation of bortezomib versus the conventional intravenous formulation in multiple myeloma.
Therapeutic advances in hematology 2012;3(2):117-24.
2012: S Muntión; Jesús F San Miguel; F M Sánchez-Guijo; Eva Villarón; S Carrancio; M Diez-Campelo; O López; Maria Consuelo Del Cañizo
Optimisation of mesenchymal stromal cells karyotyping analysis: implications for clinical use.
Transfusion medicine (Oxford, England) 2012;22(2):122-7.
2012: Bruno Paiva; Luis Palomera; Laura Rosiñol; Jesús F San Miguel; Anna Sureda; María José Terol; María-Belén Vídriales; Adrián Alegre; Joan Bladé; M Teresa Cibeira; Lourdes Cordón; Felipe de Arriba; Javier de la Rubia; Raquel de Paz; Joaquín Díaz-Mediavilla; María-Asunción Echeveste; Ana Gorosquieta; Norma C Gutiérrez; Miguel T Hernández; Juan José Lahuerta; Alejandro Martin; Joaquín Martínez-López; Maria V Mateos; María-Ángeles Montalbán; Albert Oriol
High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma.
Blood 2012;119(3):687-91.
2012: Antonio Garcia-Gomez; Pilar Hernández-Campo; Teresa Hernández-Iglesias; Francis Y Lee; Enrique M Ocio; Atanasio Pandiella; Jesús F San Miguel; Fermin Sanchez-Guijo; Carlos Santamaria; Juan F Blanco; Jesús G Briñón; Edvan Crusoe; Rosa M Fisac-Herrero; Mercedes Garayoa
Dasatinib as a bone-modifying agent: anabolic and anti-resorptive effects.
PloS one 2012;7(4):e34914.
2011: María-Victoria Mateos; María-Angeles Montalbán; Albert Oriol; Bruno Paiva; Luis Palomera; Francisco-Javier Peñalver; Josep-Maria Ribera; Joan Bargay; Enrique Bengoechea; Joan Bladé; Felipe de Arriba; Joaquín Díaz-Mediavilla; Manuela Fernández; Ramón García-Sanz; Norma C Gutiérrez; José-Mariano Hernández; Juan José Lahuerta; Alejandro Martín; Joaquín Martínez-López; María-Luisa Martín-Mateos; María-Luisa Martín-Ramos; Anna Sureda; Ana-Isabel Teruel; María-Belén Vidriales; Jesús F San Miguel
Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenance.
Blood 2011;118(17):4547-53.
2011: Miguel Alcoceba; Ana Balanzategui; M Carmen Chillón; R Corral; Ramón García-Sanz; L Marín; Patricia Martín-Jiménez; N Puig; Jesús F San Miguel; C Santamaría; María Eugenia Sarasquete; Marcos González
Frequency of HLA-A, -B and -DRB1 specificities and haplotypic associations in the population of Castilla y León (northwest-central Spain).
Tissue antigens 2011;78(4):249-55.
2011: Jesús F San Miguel; María-Victoria Mateos
Can multiple myeloma become a curable disease?
Haematologica 2011;96(9):1246-8.
2011: Antonio Palumbo; Sara Bringhen; Maria-Victoria Mateos; Jesús F San Miguel
Practical management of adverse events in multiple myeloma: can therapy be attenuated in older patients?
Blood reviews 2011;25(4):181-91.
2011: Niels W C J van de Donk; Henk M Lokhorst; Meletios Dimopoulos; Michele Cavo; Gareth Morgan; Hermann Einsele; Martin Kropff; Steve Schey; Hervé Avet-Loiseau; Heinz Ludwig; Hartmut Goldschmidt; Pieter Sonneveld; Hans E Johnsen; Joan Bladé; Jesús F San Miguel; Antonio Palumbo
Treatment of relapsed and refractory multiple myeloma in the era of novel agents.
Cancer treatment reviews 2011;37(4):266-83.
2011: Michel Delforge; Evangelos Terpos; Paul G Richardson; Ofer Shpilberg; Nuriet K Khuageva; Rudolf Schlag; Meletios A Dimopoulos; Martin Kropff; Ivan Spicka; Maria T Petrucci; Olga S Samoilova; Maria-Victoria Mateos; Hila Magen-Nativ; Hartmut Goldschmidt; Dixie Esseltine; Deborah S Ricci; Kevin Liu; William Deraedt; Andrew Cakana; Helgi van de Velde; Jesús F San Miguel
Fewer bone disease events, improvement in bone remodeling, and evidence of bone healing with bortezomib plus melphalan-prednisone vs. melphalan-prednisone in the phase III VISTA trial in multiple myeloma.
European journal of haematology 2011;86(5):372-84.
2011: Enrique Colado; Teresa Paíno; Patricia Maiso; Enrique M Ocio; Xi Chen; Stela Alvarez-Fernández; Norma C Gutiérrez; Jesús Martín-Sánchez; Juan Flores-Montero; Laura San Segundo; Mercedes Garayoa; Diego Fernández-Lázaro; María-Belén Vidriales; Carlos M Galmarini; Pablo Avilés; Carmen Cuevas; Atanasio Pandiella; Jesús F San Miguel
Zalypsis has in vitro activity in acute myeloid blasts and leukemic progenitor cells through the induction of a DNA damage response.
Haematologica 2011;96(5):687-95.
2011: Paul Richardson; Tadeusz Robak; Viktor Rossiev; Rudolf Schlag; Ofer Shpilberg; Helgi van de Velde; Marie-Christiane Vekemans; Kenneth C Anderson; Andrew Cakana; William Deraedt; Meletios Dimopoulos; Dixie Esseltine; Jian Hou; Nuriet Khuageva; Martin Kropff; Kevin Liu; Maria-Victoria Mateos; Maria Teresa Petrucci; Jesús F San Miguel
Characterization of haematological parameters with bortezomib-melphalan-prednisone versus melphalan-prednisone in newly diagnosed myeloma, with evaluation of long-term outcomes and risk of thromboembolic events with use of erythropoiesis-stimulating agents: analysis of the VISTA trial.
British journal of haematology 2011;153(2):212-21.
2011: Lucía López-Corral; Norma C Gutiérrez; María-Belén Vidriales; Maria V Mateos; Ana Rasillo; Ramón García-Sanz; Bruno Paiva; Jesús F San Miguel
The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(7):1692-700.
2011: Bruno Paiva; M Pérez-Andrés; M-B Vídriales; Julia Almeida; N de las Heras; Maria V Mateos; L López-Corral; Norma C Gutiérrez; J Blanco; A Oriol; M T Hernández; F de Arriba; A G de Coca; M-J Terol; Javier de la Rubia; Y González; A Martín; Anna Sureda; M Schmidt-Hieber; Alexander Schmitz; H E Johnsen; Juan José Lahuerta; Joan Bladé; Jesús F San Miguel; Alberto Orfao
Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma.
Leukemia 2011;25(4):697-706.
2011: Bruno Paiva; María-Belén Vídriales; José J Pérez; Ma Consuelo López-Berges; Ramón García-Sanz; Enrique M Ocio; Natalia de Las Heras; Rebeca Cuello; Alfonso García de Coca; Emilia Pardal; José Alonso; Magdalena Sierra; Abelardo Bárez; José Hernández; Lissbett Suárez; Josefina Galende; María-Victoria Mateos; Jesús F San Miguel
The clinical utility and prognostic value of multiparameter flow cytometry immunophenotyping in light-chain amyloidosis.
Blood 2011;117(13):3613-6.
2011: María Eugenia Sarasquete; Norma C Gutiérrez; Irena Misiewicz-Krzeminska; Bruno Paiva; M Carmen Chillón; Miguel Alcoceba; Ramón García-Sanz; Jesús M Hernández; Marcos González; Jesús F San Miguel
Upregulation of Dicer is more frequent in monoclonal gammopathies of undetermined significance than in multiple myeloma patients and is associated with longer survival in symptomatic myeloma patients.
Haematologica 2011;96(3):468-71.
2011: Ramón García-Sanz; Jesús M Hernández; R López; L López-Anglada; R J P Magalhães; A Martín; Enrique M Ocio; Alberto Orfao; Bruno Paiva; N Puig; Jesús F San Miguel; Belén Vidriales; T Villaescusa; A Aguilar; J Alonso; A Caballero; Javier Fernández-Calvo; D Del Carpio
Post-treatment bone marrow residual disease > 5% by flow cytometry is highly predictive of short progression-free and overall survival in patients with Waldenström's macroglobulinemia.
Clinical lymphoma, myeloma & leukemia 2011;11(1):168-71.
2011: Joan Bladé; Pieter Sonneveld; Jesús F San Miguel; Heather J Sutherland; Roman Hajek; Arnon Nagler; Andrew Spencer; Tadeusz Robak; Keith C Lantz; Sen H Zhuang; Jean-Luc Harousseau; Robert Z Orlowski
Efficacy and safety of pegylated liposomal Doxorubicin in combination with bortezomib for multiple myeloma: effects of adverse prognostic factors on outcome.
Clinical lymphoma, myeloma & leukemia 2011;11(1):44-9.
2011: Jesús F San Miguel; Meletios A Dimopoulos; Edward A Stadtmauer; S Vincent Rajkumar; David Siegel; Marie-Laure Bravo; Marta Olesnyckyj; Robert D Knight; Jerome B Zeldis; Jean-Luc Harousseau; Donna M Weber
Effects of lenalidomide and dexamethasone treatment duration on survival in patients with relapsed or refractory multiple myeloma treated with lenalidomide and dexamethasone.
Clinical lymphoma, myeloma & leukemia 2011;11(1):38-43.
2011: Elena Diaz-Rodriguez; Juan Luis García-Hernández; Ricardo López-Pérez; Bruno Paiva; Stela Álvarez-Fernández; Xi Chen; Jesús F San Miguel; Atanasio Pandiella
Deficient spindle assembly checkpoint in multiple myeloma.
PloS one 2011;6(11):e27583.
2011: Meletios A Dimopoulos; Maria-Victoria Mateos; Paul G Richardson; Rudolf Schlag; Nuriet K Khuageva; Ofer Shpilberg; Martin Kropff; Ivan Spicka; Antonio Palumbo; Ka Lung Wu; Dixie Esseltine; Kevin Liu; William Deraedt; Andrew Cakana; Helgi Van De Velde; Jesús F San Miguel
Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study.
European journal of haematology 2011;86(1):23-31.
2010: Enrique M Ocio; Jesús F San Miguel
The DAC system and associations with multiple myeloma.
Investigational new drugs 2010;28 Suppl 1():S28-35.
2010: Jean-Luc Harousseau; Antonio Palumbo; Paul G Richardson; Rudolf Schlag; Meletios A Dimopoulos; Ofer Shpilberg; Martin Kropff; Alain Kentos; Michele Cavo; Anatoly Golenkov; Mieczyslaw Komarnicki; Maria-Victoria Mateos; Dixie Esseltine; Andrew Cakana; Kevin Liu; William Deraedt; Helgi van de Velde; Jesús F San Miguel
Superior outcomes associated with complete response in newly diagnosed multiple myeloma patients treated with nonintensive therapy: analysis of the phase 3 VISTA study of bortezomib plus melphalan-prednisone versus melphalan-prednisone.
Blood 2010;116(19):3743-50.
2010: Jesús F San Miguel
Concluding remarks and future directions.
Blood reviews 2010;24 Suppl 1():S33-4.
2010: Jesús F San Miguel
Long-term disease control in multiple myeloma: the impact of the dual mechanism of action of lenalidomide. Introduction and overview.
Blood reviews 2010;24 Suppl 1():S1-3.
2010: Michel Delforge; Joan Bladé; Meletios A Dimopoulos; Thierry Facon; Martin Kropff; Heinz Ludwig; Antonio Palumbo; Philip Van Damme; Jesús F San Miguel; Pieter Sonneveld
Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues.
The lancet oncology 2010;11(11):1086-95.
2010: Juan José Lahuerta; Maria Victoria Mateos; Joaquin Martínez-López; Carlos Grande; Javier de la Rubia; Laura Rosiñol; Anna Sureda; José García-Laraña; Joaquín Díaz-Mediavilla; Miguel T Hernández-García; Dolores Carrera; Joan Besalduch; Felipe de Arriba; Albert Oriol; Lourdes Escoda; Javier García-Frade; Concepción Rivas-González; Adrián Alegre; Joan Bladé; Jesús F San Miguel
Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study.
Haematologica 2010;95(11):1913-20.
2010: Lucía López-Corral; Ramón García-Sanz; Jesús F San Miguel
[Value of serum free light chains assay in plasma cell disorders].
Medicina clínica 2010;135(8):368-74.
2010: Maria-Victoria Mateos; Paul G Richardson; Rudolf Schlag; Nuriet K Khuageva; Meletios A Dimopoulos; Ofer Shpilberg; Martin Kropff; Ivan Spicka; Maria T Petrucci; Antonio Palumbo; Olga S Samoilova; Anna Dmoszynska; Kudrat M Abdulkadyrov; Rik Schots; Bin Jiang; Dixie Esseltine; Kevin Liu; Andrew Cakana; Helgi van de Velde; Jesús F San Miguel
Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(13):2259-66.
2010: M Carmen Chillón; Carlos Santamaría; Ramón García-Sanz; Ana Balanzategui; Miguel Alcoceba; Luis Marín; María Dolores Caballero; María-Belén Vidriales; Fernando Ramos; Teresa Bernal; Joaquín Díaz-Mediavilla; María Jesús Peñarrubia; José Antonio Queizán; Pilar Giraldo; Jesús F San Miguel; Alfonso García de Coca; Maria Eugenia Sarasquete; Marcos González
Long FLT3 internal tandem duplications and reduced PML-RARα expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients.
Haematologica 2010;95(5):745-51.
2010: Enrique M Ocio; David Vilanova; Peter Atadja; Patricia Maiso; Edvan Crusoe; Diego Fernández-Lázaro; Mercedes Garayoa; Laura San-Segundo; Teresa Hernández-Iglesias; Enrique de Alava; Wenlin Shao; Yung-Mae Yao; Atanasio Pandiella; Jesús F San Miguel
In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma.
Haematologica 2010;95(5):794-803.
2010: Lucía López-Anglada; Norma C Gutiérrez; Juan L García; María V Mateos; Teresa Flores; Jesús F San Miguel
P53 deletion may drive the clinical evolution and treatment response in multiple myeloma.
European journal of haematology 2010;84(4):359-61.
2010: Norma C Gutiérrez; María Eugenia Sarasquete; I Misiewicz-Krzeminska; M Delgado; Javier De Las Rivas; F V Ticona; Encarnación Fermiñán; Patricia Martín-Jiménez; CM Chillón; A Risueño; Jesús M Hernández; Ramón García-Sanz; Marcos González; Jesús F San Miguel
Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling.
Leukemia 2010;24(3):629-37.
2010: Ernesto Pérez-Persona; Gema Mateo; Ramón García-Sanz; María-Victoria Mateos; Natalia de Las Heras; Alfonso García de Coca; José M Hernández; Josefina Galende; Guillermo Martín-Nuñez; Abelardo Bárez; José M Alonso; Alejandro Martín; Consuelo López-Berges; Alberto Orfao; Jesús F San Miguel; María-Belén Vidriales
Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells.
British journal of haematology 2010;148(1):110-4.
2010: Fermin Sanchez-Guijo; Enrique Oterino; Maria-Victoria Barbado; Soraya Carrancio; Natalia Lopez-Holgado; Sandra Muntion; Pilar Hernandez-Campo; Luis-Ignacio Sanchez-Abarca; Jose A Perez-Simon; Jesús F San Miguel; Jesús G Briñon; Maria Consuelo Del Cañizo
Both CD133(+) cells and monocytes provide significant improvement for hindlimb ischemia, although they do not transdifferentiate into endothelial cells.
Cell transplantation 2010;19(1):103-12.
2009: Meletios A Dimopoulos; Paul G Richardson; Rudolf Schlag; Nuriet K Khuageva; Ofer Shpilberg; Efstathios Kastritis; Martin Kropff; Maria T Petrucci; Michel Delforge; Julia Alexeeva; Rik Schots; Tamás Masszi; Maria-Victoria Mateos; William Deraedt; Kevin Liu; Andrew Cakana; Helgi van de Velde; Jesús F San Miguel
VMP (Bortezomib, Melphalan, and Prednisone) is active and well tolerated in newly diagnosed patients with multiple myeloma with moderately impaired renal function, and results in reversal of renal impairment: cohort analysis of the phase III VISTA study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(36):6086-93.
2009: Patricia Maiso; Enrique Colado; Enrique M Ocio; Mercedes Garayoa; J Martín; Peter Atadja; Atanasio Pandiella; Jesús F San Miguel
The synergy of panobinostat plus doxorubicin in acute myeloid leukemia suggests a role for HDAC inhibitors in the control of DNA repair.
Leukemia 2009;23(12):2265-74.
2009: Jesús F San Miguel
Relapse/Refractory myeloma patient: potential treatment guidelines.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(34):5676-7.
2009: Carlos M Santamaría; M Carmen Chillón; Ramón García-Sanz; Cristina Pérez; María Dolores Caballero; Fernando Ramos; Alfonso García de Coca; José M Alonso; Pilar Giraldo; Teresa Bernal; José A Queizán; Juan N Rodriguez; Pascual Fernández-Abellán; Abelardo Bárez; María J Peñarrubia; María-Belén Vidriales; Ana Balanzategui; Maria Eugenia Sarasquete; Miguel Alcoceba; Joaquín Díaz-Mediavilla; Jesús F San Miguel; Marcos Gonzalez
High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics.
Leukemia research 2009;33(12):1706-9.
2009: Bruno Paiva; Maria-Belén Vidriales; Gema Mateo; Jose J Pérez; Maria Angeles Montalbán; Anna Sureda; Laura Montejano; Norma C Gutiérrez; Alfonso García de Coca; Natalia de las Heras; Maria Victoria Mateos; Maria Consuelo López-Berges; Raimundo García-Boyero; Josefina Galende; Jose Hernández; Luis Palomera; Dolores Carrera; Rafael Martínez; Javier de la Rubia; Alejandro Martín; Yolanda González; Joan Bladé; Juan José Lahuerta; Alberto Orfao; Jesús F San Miguel
The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients.
Blood 2009;114(20):4369-72.
2009: Fernanda N Villanueva; José A Pérez-Simón; Fernando F Silva; Teresa T Caballero-Velázquez; Fermin F Sánchez-Guijo; Conzuelo C Cañizo; Lourdes L Vázquez; Dolores D Caballero; Jesús F San Miguel
Oral beclomethasone dipropionate for the treatment of gastrointestinal chronic graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(10):1331-6.
2009: Mercedes Garayoa; J L Garcia; C Santamaria; A Garcia-Gomez; Juan F Blanco; Atanasio Pandiella; Jesús M Hernández; Fermin Sanchez-Guijo; Maria Consuelo Del Cañizo; Norma C Gutiérrez; Jesús F San Miguel
Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors.
Leukemia 2009;23(8):1515-27.
2009: Carlos M Santamaría; M Carmen Chillón; Ramón García-Sanz; Cristina Pérez; María Dolores Caballero; Fernando Ramos; Alfonso García de Coca; José M Alonso; Pilar Giraldo; Teresa Bernal; José A Queizán; Juan N Rodriguez; Pascual Fernández-Abellán; Abelardo Bárez; María J Peñarrubia; Ana Balanzategui; María-Belén Vidriales; Maria Eugenia Sarasquete; Miguel Alcoceba; Joaquín Díaz-Mediavilla; Jesús F San Miguel; Marcos Gonzalez
Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia.
Blood 2009;114(1):148-52.
2009: Belén Blanco; José A Pérez-Simón; Luis I Sánchez-Abarca; Teresa Caballero-Velazquez; Silvia Gutierrez-Cossío; Pilar Hernández-Campo; María Díez-Campelo; Carmen Herrero-Sanchez; Concepción Rodriguez-Serrano; Carlos Santamaría; Fermín M Sánchez-Guijo; Consuelo Del Cañizo; Jesús F San Miguel
Treatment with bortezomib of human CD4+ T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population.
Haematologica 2009;94(7):975-83.
2009: Edward A Stadtmauer; Donna M Weber; Ruben Niesvizky; Andrew Belch; Miles H Prince; Jesús F San Miguel; Thierry Facon; Marta Olesnyckyj; Zhinuan Yu; Jerome B Zeldis; Robert D Knight; Meletios A Dimopoulos
Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma.
European journal of haematology 2009;82(6):426-32.
2009: Enrique M Ocio; Patricia Maiso; Xi Chen; Mercedes Garayoa; Stela Alvarez-Fernández; Laura San-Segundo; David Vilanova; Lucía López-Corral; Juan Carlos Montero; Teresa Hernández-Iglesias; Enrique de Alava; Carlos Galmarini; Pablo Avilés; Carmen Cuevas; Jesús F San Miguel; Atanasio Pandiella
Zalypsis: a novel marine-derived compound with potent antimyeloma activity that reveals high sensitivity of malignant plasma cells to DNA double-strand breaks.
Blood 2009;113(16):3781-91.
2009: O Lopez-Villar; J L Garcia; Fermin Sanchez-Guijo; Cristina Robledo; Eva Villaron; P Hernández-Campo; Natalia Lopez-Holgado; M Diez-Campelo; M V Barbado; Jose A Perez-Simon; J M Hernández-Rivas; Jesús F San Miguel; Maria Consuelo Del Cañizo
Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome.
Leukemia 2009;23(4):664-72.
2009: José Angel Hernández; Ana Eugenia Rodríguez; Marcos González; Rocío Benito; Celia Fontanillo; Virgilio Sandoval; Mercedes Romero; Guillermo Martín-Núñez; Alfonso García de Coca; Rosa Fisac; Josefina Galende; Isabel Recio; Francisco Ortuño; Juan Luis García; Javier De Las Rivas; Norma Carmen Gutiérrez; Jesús F San Miguel; Jesús María Hernández
A high number of losses in 13q14 chromosome band is associated with a worse outcome and biological differences in patients with B-cell chronic lymphoid leukemia.
Haematologica 2009;94(3):364-71.
2009: Jesús F San Miguel; María-Victoria Mateos
How to treat a newly diagnosed young patient with multiple myeloma.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2009;():555-65.
2008: Juan José Lahuerta; Maria Victoria Mateos; Joaquin Martínez-López; Laura Rosiñol; Anna Sureda; Javier de la Rubia; José García-Laraña; Rafael Martínez-Martínez; Miguel T Hernández-García; Dolores Carrera; Joan Besalduch; Felipe de Arriba; Josep-Maria Ribera; Lourdes Escoda; Belén Hernández-Ruiz; Javier García Frade; Concepción Rivas-González; Adrián Alegre; Joan Bladé; Jesús F San Miguel
Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: sequential improvement of response and achievement of complete response are associated with longer survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(35):5775-82.
2008: Joan Bladé; Pieter Sonneveld; Jesús F San Miguel; Heather J Sutherland; Roman Hajek; Arnon Nagler; Andrew Spencer; Tadeusz Robak; M Teresa Cibeira; Sen H Zhuang; Jean-Luc Harousseau; Robert Z Orlowski
Pegylated liposomal doxorubicin plus bortezomib in relapsed or refractory multiple myeloma: efficacy and safety in patients with renal function impairment.
Clinical lymphoma & myeloma 2008;8(6):352-5.
2008: Enrique M Ocio; Maria V Mateos; Patricia Maiso; Atanasio Pandiella; Jesús F San Miguel
New drugs in multiple myeloma: mechanisms of action and phase I/II clinical findings.
The lancet oncology 2008;9(12):1157-65.
2008: Carlos Santamaría; M Carmen Chillón; Ramón García-Sanz; Ana Balanzategui; Maria Eugenia Sarasquete; Miguel Alcoceba; Fernando Ramos; Teresa Bernal; José Antonio Queizán; María Jesús Peñarrubia; Pilar Giraldo; Jesús F San Miguel; Marcos Gonzalez
The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.
Haematologica 2008;93(12):1797-805.
2008: Bruno Paiva; Maria-Belén Vidriales; Jorge Cerveró; Gema Mateo; Jose J Pérez; Maria A Montalbán; Anna Sureda; Laura Montejano; Norma C Gutiérrez; Alfonso García de Coca; Natalia de Las Heras; Maria V Mateos; Maria C López-Berges; Raimundo García-Boyero; Josefina Galende; Jose Hernández; Luis Palomera; Dolores Carrera; Rafael Martínez; Javier de la Rubia; Alejandro Martín; Joan Bladé; Juan J Lahuerta; Alberto Orfao; Jesús F San Miguel
Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation.
Blood 2008;112(10):4017-23.
2008: Stephanie J Lee; Paul G Richardson; Pieter Sonneveld; Michael W Schuster; David Irwin; Jesús F San Miguel; Bruce Crawford; Joseph Massaro; Ravinder Dhawan; Sanjay Gupta; Kenneth C Anderson
Bortezomib is associated with better health-related quality of life than high-dose dexamethasone in patients with relapsed multiple myeloma: results from the APEX study.
British journal of haematology 2008;143(4):511-9.
2008: Miguel Alcoceba; Ana Balanzategui; María Díez-Campelo; Patricia Martín-Jiménez; Maria Eugenia Sarasquete; M Carmen Chillón; Carlos Santamaría; José A Pérez-Simón; Luis Marín; María Dolores Caballero; Jesús F San Miguel; Ramón García-Sanz; Marcos González
Clinical and prognostic value of discrepancies in microsatellite DNA regions between recipient and donor in human leukocyte antigen-identical allogeneic transplantation setting.
Transplantation 2008;86(7):983-90.
2008: Francis Ayuk; Jose A Perez-Simon; Avichai Shimoni; Anna Sureda; Tatjana Zabelina; Rainer Schwerdtfeger; Rodrigo Martino; Herbert G Sayer; Adrián Alegre; Juan José Lahuerta; Djordje Atanackovic; Christine Wolschke; Arnon Nagler; Axel R Zander; Jesús F San Miguel; Nicolaus Kröger
Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation.
Haematologica 2008;93(9):1343-50.
2008: Soraya Tabera; José A Pérez-Simón; María Díez-Campelo; Luis I Sánchez-Abarca; Belén Blanco; Antonio López; Ana Benito; Enrique M Ocio; Fermín M Sánchez-Guijo; Consuelo Cañizo; Jesús F San Miguel
The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes.
Haematologica 2008;93(9):1301-9.
2008: Jesús F San Miguel; Rudolf Schlag; Nuriet K Khuageva; Meletios A Dimopoulos; Ofer Shpilberg; Martin Kropff; Ivan Spicka; Maria T Petrucci; Antonio Palumbo; Olga S Samoilova; Anna Dmoszynska; Kudrat M Abdulkadyrov; Rik Schots; Bin Jiang; Maria-Victoria Mateos; Kenneth C Anderson; Dixie Esseltine; Kevin Liu; Andrew Cakana; Helgi van de Velde; Paul G Richardson
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.
The New England journal of medicine 2008;359(9):906-17.
2008: Soraya Carrancio; Natalia López-Holgado; Fermín M Sánchez-Guijo; Eva Villarón; Victoria Barbado; Soraya Tabera; María Díez-Campelo; Juan Blanco; Jesús F San Miguel; Maria Consuelo Del Cañizo
Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification.
Experimental hematology 2008;36(8):1014-21.
2008: José A Pérez-Simón; Rodrigo Martino; Dolores Caballero; David Valcarcel; Noemi Rebollo; Rafael de La Cámara; Javier Pérez de Oteiza; Inmaculada Heras; Maria V Calvo; Jordi Sierra; Jesús F San Miguel
Reduced-intensity conditioning allogeneic transplantation from unrelated donors: evaluation of mycophenolate mofetil plus cyclosporin A as graft-versus-host disease prophylaxis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(6):664-71.
2008: Gema Mateo; M Angeles Montalbán; Maria-Belén Vidriales; Juan J Lahuerta; Maria V Mateos; Norma Gutiérrez; Laura Rosiñol; Laura Montejano; Joan Bladé; Rafael Martínez; Javier de la Rubia; Joaquín Diaz-Mediavilla; Anna Sureda; José M Ribera; José M Ojanguren; Felipe de Arriba; Luis Palomera; María José Terol; Alberto Orfao; Jesús F San Miguel
Prognostic value of immunophenotyping in multiple myeloma: a study by the PETHEMA/GEM cooperative study groups on patients uniformly treated with high-dose therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(16):2737-44.
2008: Juan Carlos Montero; Ricardo López-Pérez; Jesús F San Miguel; Atanasio Pandiella
Expression of c-Kit isoforms in multiple myeloma: differences in signaling and drug sensitivity.
Haematologica 2008;93(6):851-9.
2008: M Alcoceba; L Marín; A Balanzategui; Maria Eugenia Sarasquete; P Martín-Jiménez; M C Chillón; R Corral; E Pérez-Persona; F J Fernández-Calvo; J M Hernández; J Bladé; J J Lahuerta; M González; Jesús F San Miguel; R García-Sanz
The presence of DRB1*01 allele in multiple myeloma patients is associated with an indolent disease.
Tissue antigens 2008;71(6):548-51.
2008: Patricia Maiso; Enrique M Ocio; Mercedes Garayoa; Juan Carlos Montero; Francesco Hofmann; Carlos García-Echeverría; Johann Zimmermann; Atanasio Pandiella; Jesús F San Miguel
The insulin-like growth factor-I receptor inhibitor NVP-AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cells.
British journal of haematology 2008;141(4):470-82.
2008: María-Victoria Mateos; José M Hernández; Miguel T Hernández; Norma C Gutiérrez; Luis Palomera; Marta Fuertes; Pedro Garcia-Sanchez; Juán J Lahuerta; Javier de la Rubia; María José Terol; Anna Sureda; Joan Bargay; Paz Ribas; Adrian Alegre; Felipe de Arriba; Albert Oriol; Dolores Carrera; José García-Laraña; Ramón García-Sanz; Joan Bladé; Felipe Prósper; Gema Mateo; Dixie Esseltine; Helgi van de Velde; Jesús F San Miguel
Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression.
Haematologica 2008;93(4):560-5.
2008: Jesús F San Miguel; Paul G Richardson; Pieter Sonneveld; M W Schuster; David Irwin; E A Stadtmauer; T Facon; Jean-Luc Harousseau; D Ben-Yehuda; Sagar Lonial; H Goldschmidt; D Reece; Joan Bladé; Mario Boccadoro; J D Cavenagh; R Neuwirth; A L Boral; Dixie Esseltine; Kenneth C Anderson
Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study.
Leukemia 2008;22(4):842-9.
2008: Marta Martín-Ayuso; Julia Almeida; Martín Pérez-Andrés; Rebeca Cuello; Josefina Galende; Maria Isabel González-Fraile; Guillermo Martín-Nuñez; F Ortega; Maria Jesús Rodríguez; Jesús F San Miguel; Alberto Orfao
Peripheral blood dendritic cell subsets from patients with monoclonal gammopathies show an abnormal distribution and are functionally impaired.
The oncologist 2008;13(1):82-92.
2008: Enrique Colado; Stela Alvarez-Fernández; Patricia Maiso; Jesús Martín-Sánchez; Maria Belén Vidriales; Mercedes Garayoa; Enrique M Ocio; Juan Carlos Montero; Atanasio Pandiella; Jesús F San Miguel
The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype.
Haematologica 2008;93(1):57-66.
2007: Maria V Mateos; Jesús F San Miguel
Bortezomib in multiple myeloma.
Best practice & research. Clinical haematology 2007;20(4):701-15.
2007: Patricia Martín-Jiménez; Ramón García-Sanz; David González; Ana Balanzategui; José J Pérez; María Dolores Caballero; María Eugenia Sarasquete; Josefina Galende; Alberto Orfao; Ma Consuelo López-Berges; Jesús F San Miguel; Marcos González
Molecular characterization of complete and incomplete immunoglobulin heavy chain gene rearrangements in hairy cell leukemia.
Clinical lymphoma & myeloma 2007;7(9):573-9.
2007: David González; Mirjam van der Burg; Ramón García-Sanz; James A Fenton; Anton Langerak; Marcos González; Jacques J M van Dongen; Jesús F San Miguel; Gareth J Morgan
Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma.
Blood 2007;110(9):3112-21.
2007: Eva Villaron; Julia Almeida; Natalia Lopez-Holgado; Fermin Sanchez-Guijo; Mercedes Alberca; Belén Blanco; Luis-Ignacio Sanchez-Abarca; O Lopez; Jose A Perez-Simon; Jesús F San Miguel; Maria Consuelo Del Cañizo
In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2007;37(2):145-56.
2007: Ernesto Pérez-Persona; María-Belén Vidriales; Gema Mateo; Ramón García-Sanz; Maria V Mateos; Alfonso García de Coca; Josefina Galende; Guillermo Martín-Nuñez; José M Alonso; Natalia de Las Heras; Jesús M Hernández; Alejandro Martín; Consuelo López-Berges; Alberto Orfao; Jesús F San Miguel
New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells.
Blood 2007;110(7):2586-92.
2007: José Bagán; Juan Blade; Jose Manuel Cozar; Manuel Constela; Ramón García-Sanz; Francisco Gómez Veiga; Juan José Lahuerta; Ana Lluch; Bartomeu Massuti; Juan Morote; Jesús F San Miguel; Eduardo Solsona
Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates.
Medicina oral, patología oral y cirugía bucal 2007;12(4):E336-40.
2007: Ramón García-Sanz; Maria V Mateos; Jesús F San Miguel
[Multiple myeloma].
Medicina clínica 2007;129(3):104-15.
2007: Paul G Richardson; Pieter Sonneveld; Michael W Schuster; David Irwin; Edward A Stadtmauer; Thierry Facon; Jean-Luc Harousseau; Dina Ben-Yehuda; Sagar Lonial; Jesús F San Miguel; Jamie Cavenagh; Kenneth C Anderson
Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myeloma.
British journal of haematology 2007;137(5):429-35.
2007: Jean-Marie Ramirez; Enrique M Ocio; Jesús F San Miguel; Atanasio Pandiella
Pemetrexed acts as an antimyeloma agent by provoking cell cycle blockade and apoptosis.
Leukemia 2007;21(4):797-804.
2007: Carlos Santamaría; M Carmen Chillón; Carina Fernández; Patricia Martín-Jiménez; Ana Balanzategui; Ramón García-Sanz; Jesús F San Miguel; Marcos-Gonzalez González
Using quantification of the PML-RARalpha transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia.
Haematologica 2007;92(3):315-22.
2007: Norma C Gutiérrez; Enrique M Ocio; Javier De Las Rivas; Patricia Maiso; M Delgado; Encarnación Fermiñán; M J Arcos; María Luz Sánchez; Jesús M Hernández; Jesús F San Miguel
Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals.
Leukemia 2007;21(3):541-9.
2007: Natalia López-Holgado; Mercedes Alberca; Fermín Sánchez Guijo; Eva Villarón; J Almeida; Alejandro Martín; A Armellini; C García; Belén Blanco; Ignacio Sánchez-Abarca; S Martín; José A Pérez-Simón; R García-Sanz; Jesús F San Miguel; Maria Consuelo Del Cañizo
Short-term endothelial progenitor cell colonies are composed of monocytes and do not acquire endothelial markers.
Cytotherapy 2007;9(1):14-22.
2007: Enrique M Ocio; Roelandt F J Schop; B Gonzalez; Scott A Van Wier; J M Hernandez-Rivas; Norma C Gutierrez; Ramon Garcia-Sanz; María Jesús Moro; C Aguilera; Jose Hernandez; R Xu; Philip R Greipp; Angela Dispenzieri; Syed M Jalal; Martha Q Lacy; N Gonzalez-Paz; Morie A Gertz; Jesús F San Miguel; Rafael Fonseca
6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis.
British journal of haematology 2007;136(1):80-6.
2007: Patricia Martín-Jiménez; Ramón García-Sanz; María Eugenia Sarasquete; Enrique M Ocio; José J Pérez; Marcos González; Jesús F San Miguel
Functional class switch recombination may occur 'in vivo' in Waldenström macroglobulinaemia.
British journal of haematology 2007;136(1):114-6.
2007: Norma C Gutiérrez; Mariana Castellanos; M Luisa Martín; Maria V Mateos; Jesús M Hernández; M Fernández; Dolores Carrera; Laura Rosiñol; Josep-Maria Ribera; J M Ojanguren; Luis Palomera; Santiago Gardella; Lourdes Escoda; J C Hernández-Boluda; J L Bello; Javier de la Rubia; Juan José Lahuerta; Jesús F San Miguel
Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis.
Leukemia 2007;21(1):143-50.
2007: J R Gonzalez-Porras; F Martin-Herrero; Ramon Garcia-Sanz; M L Lopez; Ana Balanzategui; Maria V Mateos; P Pavon; M Gonzalez; Ignacio Alberca; Jesús F San Miguel
Hyperhomocysteinemia is a risk factor of recurrent coronary event in young patients irrespective to the MTHFR C677T polymorphism.
Thrombosis research 2007;119(6):691-8.
2006: Ramón García-Sanz; Jesús M Hernández; A Sureda; José García-Laraña; Felipe Prósper; Adrián Alegre; Abelardo Bárez; Maria V Mateos; Jesús F San Miguel
Pegylated liposomal doxorubicin, melphalan and prednisone therapy for elderly patients with multiple myeloma.
Hematological oncology 2006;24(4):205-11.
2006: Ignacio Garcia Escobar; Dolores Caballero Barrigon; Pilar Tamayo; Jose A Perez-Simon; Maria Vitoria Mateos; Jose Ramon Garcia; Jesús F San Miguel
Prognostic impact of pretransplantation computed tomography and gallium scans in patients with Hodgkin lymphoma with poor prognosis undergoing hematopoietic stem cell transplantation.
Clinical lymphoma & myeloma 2006;7(3):217-25.
2006: María Eugenia Sarasquete; Ramón García-Sanz; Adriana Armellini; Marta Fuertes; Patricia Martín-Jiménez; Magdalena Sierra; María Del Carmen Chillón; Miguel Alcoceba; Ana Balanzategui; Fernando Ortega; Jesús M Hernández; Anna Sureda; Luis Palomera; Marcos González; Jesús F San Miguel
The association of increased p14ARF/p16INK4a and p15INK4a gene expression with proliferative activity and the clinical course of multiple myeloma.
Haematologica 2006;91(11):1551-4.
2006: Maria V Mateos; Jesús M Hernández; Miguel-T Hernández; Norma C Gutiérrez; Luis Palomera; Marta Fuertes; Joaquín Díaz-Mediavilla; Juan José Lahuerta; Javier de la Rubia; María José Terol; Anna Sureda; Joan Bargay; Paz Ribas; Felipe de Arriba; Adrián Alegre; Albert Oriol; Dolores Carrera; José García-Laraña; Ramón García-Sanz; Joan Bladé; Felipe Prósper; Gema Mateo; Dixie Esseltine; Helgi van de Velde; Jesús F San Miguel
Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study.
Blood 2006;108(7):2165-72.
2006: Cristina Castilla; José A Pérez-Simón; Fermin Sanchez-Guijo; María Díez-Campelo; Enrique M Ocio; E Pérez-Persona; O López-Villar; Lourdes Vazquez; Dolores Caballero; Jesús F San Miguel
Oral beclomethasone dipropionate for the treatment of gastrointestinal acute graft-versus-host disease (GVHD).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(9):936-41.
2006: Magdalena Sierra; Alvaro Alonso; María D Odero; M Belén Gonzalez; Idoya Lahortiga; José J Pérez; Juan L García; Norma C Gutiérrez; María J Calasanz; Jesús F San Miguel; Jesús M Hernández
Geographic differences in the incidence of cytogenetic abnormalities of acute myelogenous leukemia (AML) in Spain.
Leukemia research 2006;30(8):943-8.
2006: Jesús F San Miguel; Norma C Gutiérrez; Gema Mateo; Alberto Orfao
Conventional diagnostics in multiple myeloma.
European journal of cancer (Oxford, England : 1990) 2006;42(11):1510-9.
2006: Luis Ramos; José Antonio de Las Heras; Sergio Sánchez; José Ramón González-Porras; Rafael González; Maria Victoria Mateos; Jesús F San Miguel
Medium-term results of percutaneous vertebroplasty in multiple myeloma.
European journal of haematology 2006;77(1):7-13.
2006: Niels W C J van de Donk; Nicolaus Kröger; Ute Hegenbart; Paolo Corradini; Jesús F San Miguel; Hartmut Goldschmidt; Jose A Perez-Simon; Maeike Zijlmans; Reinier A P Raymakers; Vittorio Montefusco; Francis Ayuk; Marinus H J van Oers; Arnon Nagler; Leo F Verdonck; Henk M Lokhorst
Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma.
Bone marrow transplantation 2006;37(12):1135-41.
2006: Patricia Maiso; Xonia Carvajal-Vergara; Enrique M Ocio; Ricardo López-Pérez; Gema Mateo; Norma C Gutiérrez; Peter Atadja; Atanasio Pandiella; Jesús F San Miguel
The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance.
Cancer research 2006;66(11):5781-9.
2006: Niels W C J van de Donk; Nicolaus Kröger; Ute Hegenbart; Paolo Corradini; Jesús F San Miguel; Hartmut Goldschmidt; Jose A Perez-Simon; Maeike Zijlmans; Reinier A P Raymakers; Vittorio Montefusco; Francis Ayuk; Marinus H J van Oers; Arnon Nagler; Leo F Verdonck; Henk M Lokhorst
Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma.
Blood 2006;107(8):3415-6.
2006: Martin Pérez-Andres; Julia Almeida; Marta Martin-Ayuso; María Jesús Moro; Guillermo Martin-Nuñez; Josefina Galende; Jose Hernandez; Gema Mateo; Jesús F San Miguel; Alberto Orfao
Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire.
Cancer 2006;106(6):1296-305.
2006: Maria Luz Sanchez; Julia Almeida; Antonio Lopez; José María Sayagues; Ana Rasillo; Eugenia A Sarasquete; Ana Balanzategui; María Dolores Tabernero; Joaquin Diaz-Mediavilla; Carmen Barrachina; Artur Paiva; Marcos Gonzalez; Jesús F San Miguel; Alberto Orfao
Heterogeneity of neoplastic cells in B-cell chronic lymphoproliferative disorders: biclonality versus intraclonal evolution of a single tumor cell clone.
Haematologica 2006;91(3):331-9.
2006: José A Pérez-Simón; A Sureda; F Fernández-Aviles; A Sampol; José Rafael Cabrera; Dolores Caballero; Rodrigo Martino; J Petit; José F Tomás; José María Moraleda; Adrián Alegre; Consuelo Cañizo; Salut Brunet; Laura Rosiñol; Juan José Lahuerta; José L Díez-Martín; A León; A García; Lourdes Vazquez; Jorge Sierra; Jesús F San Miguel
Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients.
Leukemia 2006;20(3):542-5.
2006: J Mateos; José A Pérez-Simón; Dolores Caballero; Cristina Castilla; O Lopez; E Perez; Consuelo Cañizo; Lourdes Vazquez; Jesús F San Miguel
Vincristine is an effective therapeutic approach for transplantation-associated thrombotic microangiopathy.
Bone marrow transplantation 2006;37(3):337-8.
2006: Eva Villaron; Jose A Perez-Simon; Jesús F San Miguel; Consuelo del Cañizo
Bone marrow mesenchymal stem cells chimerism after allogeneic hematopoietic transplantation.
Experimental hematology 2006;34(1):7.
2005: Lourdes Vazquez; J J Mateos; C Sanz-Rodriguez; E Perez; Dolores Caballero; Jesús F San Miguel
Successful treatment of rhinocerebral zygomycosis with a combination of caspofungin and liposomal amphotericin B.
Haematologica 2005;90(12 Suppl):ECR39.
2005: María Eugenia Sarasquete; Ramón García-Sanz; David González; Joaquín Martínez; Gema Mateo; Pilar Martínez; José Maria Ribera; Jesús M Hernández; Juan José Lahuerta; Alberto Orfão; Marcos González; Jesús F San Miguel
Minimal residual disease monitoring in multiple myeloma: a comparison between allelic-specific oligonucleotide real-time quantitative polymerase chain reaction and flow cytometry.
Haematologica 2005;90(10):1365-72.
2005: Agnes Fütterer; Miguel R Campanero; Esther Leonardo; Luis M Criado; Juana M Flores; Jesús M Hernández; Jesús F San Miguel; Carlos Martínez-A
Dido gene expression alterations are implicated in the induction of hematological myeloid neoplasms.
The Journal of clinical investigation 2005;115(9):2351-62.
2005: José A Pérez-Simón; María Díez-Campelo; Rodrigo Martino; Salut Brunet; Alvaro Urbano; María Dolores Caballero; Angel de León; David Valcárcel; Enric Carreras; Maria Consuelo Del Cañizo; Jesús López-Fidalgo; Jorge Sierra; Jesús F San Miguel
Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation.
British journal of haematology 2005;130(3):394-403.
2005: Fermin Sanchez-Guijo; Luis-Ignacio Sanchez-Abarca; Eva Villaron; Natalia Lopez-Holgado; Mercedes Alberca; Lourdes Vazquez; Jose A Perez-Simon; Jesus Lopez-Fidalgo; Alberto Orfao; María Dolores Caballero; Maria Consuelo Del Cañizo; Jesús F San Miguel
Posttransplant hematopoiesis in patients undergoing sibling allogeneic stem cell transplantation reflects that of their respective donors although with a lower functional capability.
Experimental hematology 2005;33(8):935-43.
2005: David González; Marcos González; Ana Balanzategui; María Eugenia Sarasquete; Ricardo López-Pérez; M Carmen Chillón; Ramón García-Sanz; Jesús F San Miguel
Molecular characteristics and gene segment usage in IGH gene rearrangements in multiple myeloma.
Haematologica 2005;90(7):906-13.
2005: Magdalena Sierra; Jesús M Hernández; Juan L García; Norma C Gutiérrez; José J Pérez; María-Belén Vidriales; Fernando Ramos; Jesús M Hernández; Mercedes Romero; M Belén González; Josefina Galende; Jesús F San Miguel
Hematological, immunophenotypic, and cytogenetic characteristics of acute myeloblastic leukemia with trisomy 11.
Cancer genetics and cytogenetics 2005;160(1):68-72.
2005: Paul G Richardson; Pieter Sonneveld; Michael W Schuster; David Irwin; Edward A Stadtmauer; Thierry Facon; Jean-Luc Harousseau; Dina Ben-Yehuda; Sagar Lonial; Hartmut Goldschmidt; Donna Reece; Jesús F San Miguel; Joan Bladé; Mario Boccadoro; Jamie Cavenagh; William S Dalton; Anthony Boral; Dixie Esseltine; Jane B Porter; David P Schenkein; Kenneth C Anderson
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma.
The New England journal of medicine 2005;352(24):2487-98.
2005: Rodrigo Martino; José A Pérez-Simón; Estela Moreno; José M Queraltó; Dolores Caballero; Marivi Mateos; Anna Sureda; Consuelo Cañizo; Salut Brunet; Javier Briones; Lourdes Vazquez; Ana Clopés; Jesús F San Miguel; Jorge Sierra
Reduced-intensity conditioning allogeneic blood stem cell transplantation with fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(6):437-47.
2005: Jesús M Hernández; Cristina Castilla; Norma C Gutiérrez; I M Isidro; M Delgado; Javier De Las Rivas; Encarnación Fermiñán; Juan L García; Enrique M Ocio; Maria Consuelo Del Cañizo; Jesús F San Miguel
Mobilisation with G-CSF in healthy donors promotes a high but temporal deregulation of genes.
Leukemia 2005;19(6):1088-91.
2005: Xonia Carvajal-Vergara; Soraya Tabera; Juan Carlos Montero; Azucena Esparís-Ogando; Ricardo López-Pérez; Gema Mateo; Norma C Gutiérrez; Marisa Parmo-Cabañas; Joaquin Teixidó; Jesús F San Miguel; Atanasio Pandiella
Multifunctional role of Erk5 in multiple myeloma.
Blood 2005;105(11):4492-9.
2005: Gema Mateo; Mariana Castellanos; Ana Rasillo; Norma C Gutiérrez; Maria A Montalbán; M Luisa Martín; Jesús Ma Hernández; Ma Consuelo López-Berges; Laura Montejano; Joan Bladé; Maria V Mateos; Anna Sureda; Javier de la Rubia; Joaquín Díaz-Mediavilla; Atanasio Pandiella; Juan José Lahuerta; Alberto Orfao; Jesús F San Miguel
Genetic abnormalities and patterns of antigenic expression in multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(10):3661-7.
2005: Fermin Sanchez-Guijo; Luis-Ignacio Sanchez-Abarca; Clara Bueno; Eva Villaron; Natalia Lopez-Holgado; Lourdes Vazquez; Jesus Lopez-Fidalgo; Jose A Perez-Simon; María Dolores Caballero; Maria Consuelo Del Cañizo; Alberto Orfao; Jesús F San Miguel
Long-term immune recovery of patients undergoing allogeneic stem cell transplantation: a comparison with their respective sibling donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(5):354-61.
2005: Daniel Primo; María Dolores Tabernero; J J Perez; Ana Rasillo; José María Sayagués; Ana Belén Espinosa; Maria-Consuelo Lopez-Berges; Ramón García-Sanz; Norma C Gutierrez; Jesus M Hernandez; M Romero; C S Osuna; M Giralt; M Barbon; Jesús F San Miguel; Alberto Orfao
Genetic heterogeneity of BCR/ABL+ adult B-cell precursor acute lymphoblastic leukemia: impact on the clinical, biological and immunophenotypical disease characteristics.
Leukemia 2005;19(5):713-20.
2005: Azucena Esparís-Ogando; Adrián Alegre; Beatriz Aguado; Gema Mateo; Norma C Gutiérrez; Joan Bladé; David P Schenkein; Atanasio Pandiella; Jesús F San Miguel
Bortezomib is an efficient agent in plasma cell leukemias.
International journal of cancer. Journal international du cancer 2005;114(4):665-7.
2005: Enrique M Ocio; Fermin Sanchez-Guijo; Maria Diez-Campelo; Cristina Castilla; Oscar J Blanco; Dolores Caballero; Jesús F San Miguel
Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena.
American journal of hematology 2005;78(4):302-5.
2005: Enrique M Ocio; Gema Mateo; Belen Vidriales; Maria-Consuelo Lopez-Berges; Ramon Garcia-Sanz; Jesus M Hernandez; Alberto Orfao; Jesús F San Miguel
Cell cycle analysis of Waldenstrom's macroglobulinemia.
Clinical lymphoma 2005;5(4):250-2.
2005: Enrique M Ocio; Jesus M Hernandez; Gema Mateo; Maria Luz Sanchez; Belen Gonzalez; Belen Vidriales; Norma C Gutierrez; Alberto Orfao; Jesús F San Miguel
Immunophenotypic and cytogenetic comparison of Waldenstrom's macroglobulinemia with splenic marginal zone lymphoma.
Clinical lymphoma 2005;5(4):241-5.
2005: Natalia López-Holgado; Carmen Pata; Eva Villarón; Fermín Sánchez Guijo; Mercedes Alberca; Alejandro Martín; Mercedes Corral; Ignacio Sánchez-Abarca; José A Pérez-Simón; Jesús F San Miguel; Maria Consuelo Del Cañizo
Long-term bone marrow culture data are the most powerful predictor of peripheral blood progenitor cell mobilization in healthy donors.
Haematologica 2005;90(3):353-9.
2005: M Pérez-Andrés; Julia Almeida; Marta Martín-Ayuso; María Jesús Moro; G Martín-Nuñez; Josefina Galende; D Borrego; M J Rodríguez; F Ortega; Jose Hernandez; I Moreno; M Domínguez; Gema Mateo; Jesús F San Miguel; Alberto Orfao
Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment.
Leukemia 2005;19(3):449-55.
2005: Norma C Gutiérrez; Ricardo López-Pérez; Jesús M Hernández; I Isidro; B González; M Delgado; Encarnación Fermiñán; Juan L García; L Vázquez; Marcos González; Jesús F San Miguel
Gene expression profile reveals deregulation of genes with relevant functions in the different subclasses of acute myeloid leukemia.
Leukemia 2005;19(3):402-9.
2005: María Díez-Campelo; José A Pérez-Simón; Enrique M Ocio; Cristina Castilla; José Ramón González-Porras; Fermín Sánchez Guijo; L Vázquez; María Dolores Caballero; MC Cañizo; Jesús F San Miguel
CD34 + cell dose and outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation.
Leukemia & lymphoma 2005;46(2):177-83.
2005: Jesús F San Miguel; Ramón García-Sanz
Prognostic features of multiple myeloma.
Best practice & research. Clinical haematology 2005;18(4):569-83.
2005: Alejandro Martín; José A Pérez-Simón; María Dolores Caballero; Natalia López-Holgado; Lourdes Vázquez; Maria Consuelo Del Cañizo; Jesús F San Miguel
Effect of pre-transplant cumulative doses of chemotherapeutic drugs on early and long-term hematological recovery after autologous bone-marrow transplantation for lymphoma.
Haematologica 2005;90(1):78-85.
2005: Lilia Suárez; María-Belén Vidriales; María-José Moreno; Antonio López; José García-Laraña; Cristina Pérez-López; Mar Tormo; Esperanza Lavilla; Ma Consuelo López-Berges; María de Santiago; Jesús F San Miguel; Alberto Orfao
Differences in anti-apoptotic and multidrug resistance phenotypes in elderly and young acute myeloid leukemia patients are related to the maturation of blast cells.
Haematologica 2005;90(1):54-9.
2004: Ramón García-Sanz; M I González-Fraile; Gema Mateo; Jesús M Hernández; Ma Consuelo López-Berges; N de las Heras; Javier Fernández-Calvo; F Ortega; Juan A Portero; Abelardo Bárez; Josefina Galende; Alberto Orfão; Jesús F San Miguel
Proliferative activity of plasma cells is the most relevant prognostic factor in elderly multiple myeloma patients.
International journal of cancer. Journal international du cancer 2004;112(5):884-9.
2004: Eva Villaron; Julia Almeida; Natalia López-Holgado; Miguel Alcoceba; Luis Ignacio Sánchez-Abarca; Fermin Sanchez-Guijo; Mercedes Alberca; Jose Antonio Pérez-Simon; Jesús F San Miguel; Maria Consuelo Del Cañizo
Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation.
Haematologica 2004;89(12):1421-7.
2004: Natalia López-Holgado; Jose Luis Arroyo; Carmen Pata; Eva Villarón; Fermín Sánchez Guijo; Alejandro Martín; Jesús-María Hernández-Rivas; Alberto Orfao; Jesús F San Miguel; M Consuelo Del Cañizo Fernández-Roldán
Analysis of hematopoietic progenitor cells in patients with myelodysplastic syndromes according to their cytogenetic abnormalities.
Leukemia research 2004;28(11):1181-7.
2004: Norma C Gutiérrez; Juan L García; Jesús M Hernández; Eva Lumbreras; Mariana Castellanos; Ana Rasillo; Gema Mateo; Jesús M Hernández; Sonia Pérez; Alberto Orfao; Jesús F San Miguel
Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myeloma.
Blood 2004;104(9):2661-6.
2004: M Belén González; Jesús M Hernández; Juan L García; Eva Lumbreras; Mariana Castellanos; Jesús M Hernández; Javier Fernández-Calvo; Norma C Gutiérrez; Jesús F San Miguel
The value of fluorescence in situ hybridization for the detection of 11q in multiple myeloma.
Haematologica 2004;89(10):1213-8.
2004: Jesús M Hernández; Ramón García-Sanz; E Golvano; Joan Bladé; J Fernandez-Calvo; Jesús Trujillo; J A Soler; Santiago Gardella; Félix Carbonell; Gema Mateo; Jesús F San Miguel
Randomized comparison of dexamethasone combined with melphalan versus melphalan with prednisone in the treatment of elderly patients with multiple myeloma.
British journal of haematology 2004;127(2):159-64.
2004: Nicolaus Kröger; Jose A Perez-Simon; Han Myint; Hans Klingemann; Avichai Shimoni; Arnon Nagler; Rodrigo Martino; Adrian Alegre; Jose F Tomas; Rainer Schwerdtfeger; Michael Kiehl; Axel A Fauser; Herbert G Sayer; Angel Leon; Jörg Beyer; Tatjana Zabelina; Francis Ayuk; Jesús F San Miguel; Ronald Brand; Axel R Zander
Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(10):698-708.
2004: José A Pérez-Simón; Dolores Caballero; Maria V Mateos; Jesús F San Miguel
Graft vs. host disease and graft vs. myeloma effect after non-myeloablative allogeneic transplantation.
Leukemia & lymphoma 2004;45(9):1725-9.
2004: M Pérez-Andrés; M Santiago; J Almeida; Gema Mateo; A Porwit-MacDonald; E Bjorklund; G Valet; Jaco Kraan; Jan W Gratama; Jean-Luc D'Hautcourt; H Merle-Beral; M Lima; M A Montalban; Jesús F San Miguel; I Orfao
Immunophenotypic approach to the identification and characterization of clonal plasma cells from patients with monoclonal gammopathies.
Journal of biological regulators and homeostatic agents 2004;18(3-4):392-8.
2004: L Suárez; María-Belén Vidriales; G Sanz; Antonio López; Ma Consuelo López-Berges; María de Santiago; Luis Palomera; T Bernal; M E Pérez de Equiza; Jesús F San Miguel; Alberto Orfao
Expression of APO2.7, bcl-2 and bax apoptosis-associated proteins in CD34- bone marrow cell compartments from patients with myelodysplastic syndromes.
Leukemia 2004;18(7):1311-3.
2004: Nicolaus Kröger; Georgia Schilling; Hermann Einsele; Peter Liebisch; Avichai Shimoni; Arnon Nagler; Jose A Perez-Simon; Jesús F San Miguel; Michael Kiehl; Axel A Fauser; Rainer Schwerdtfeger; Hannes Wandt; Herbert G Sayer; Han Myint; Hans Klingemann; Tatjana Zabelina; Judith Dierlamm; Axel Hinke; Axel R Zander
Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation.
Blood 2004;103(11):4056-61.
2004: M Belén González; Norma C Gutiérrez; Juan L García; Eric F P M Schoenmakers; Francesc Solé; María J Calasanz; Jesús F San Miguel; Jesús M Hernández
Heterogeneity of structural abnormalities in the 7q31.3 approximately q34 region in myeloid malignancies.
Cancer genetics and cytogenetics 2004;150(2):136-43.
2004: M Perez-Andres; Julia Almeida; M Martin-Ayuso; María Jesús Moro; M A Garcia-Marcos; I Moreno; M Dominguez; Josefina Galende; N Heras; M I Gonzalez; Jesús F San Miguel; Alberto Orfao
Interaction between clonal plasma cells and the immune system in plasma cell dyscrasias.
Journal of biological regulators and homeostatic agents 2004;18(2):161-5.
2004: Ramón García-Sanz; José Ramón González-Porras; J M Hernández; M Polo-Zarzuela; A Sureda; C Barrenetxea; Luis Palomera; R López; C Grande-García; Adrián Alegre; M Vargas-Pabón; O N Gutiérrez; J A Rodríguez; Jesús F San Miguel
The oral combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is effective in relapsed/refractory multiple myeloma.
Leukemia 2004;18(4):856-63.
2004: Alejandro Martín; José A Pérez-Simón; María Dolores Caballero; N López; Ramón García-Sanz; Lourdes Vázquez; Maria Consuelo Del Cañizo; Jesús F San Miguel
Effect of cumulative etoposide doses on the outcome of autologous peripheral-blood progenitor-cell transplantation for lymphoma.
Bone marrow transplantation 2004;33(6):579-87.
2004: Pablo Menendez; A Vargas; C Bueno; Susana Barrena; Julia Almeida; María de Santiago; Antonio López; Sergio Roa; Jesús F San Miguel; Alberto Orfao
Quantitative analysis of bcl-2 expression in normal and leukemic human B-cell differentiation.
Leukemia 2004;18(3):491-8.
2004: Jesús M Hernández; Begoña Suquía; José A Queizan; Rosa M Fisac; José J Sanchez; Francisco J Fernández-Calvo; Ramón García-Sanz; Carmen Olivier; Abelardo Bárez; María J Calmuntia; Javier García-Frade; Juan A Portero; Rosa López; Carmen Aguilera; Jose A Navajo; Jesús F San Miguel
Bone remodelation markers are useful in the management of monoclonal gammopathies.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(6):480-8.
2004: Jose Luis Arroyo; Ma Eugenia Fernández; Jesús M Hernández; Alberto Orfao; Jesús F San Miguel; Maria Consuelo Del Cañizo
Impact of immunophenotype on prognosis of patients with myelodysplastic syndromes. Its value in patients without karyotypic abnormalities.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(3):227-33.
2004: Clara Bueno; Julia Almeida; Paulo Lucio; Josefa Marco; Raimundo Garcia; Jose Maria de Pablos; Antonio Parreira; Fernando Ramos; Francisco Ruiz-Cabello; Dimas Suarez-Vilela; Jesús F San Miguel; Alberto Orfao
Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignancies.
Haematologica 2004;89(1):58-69.
2004: José A Pérez-Simón; I García-Escobar; J Martinez; Lourdes Vazquez; Dolores Caballero; Consuelo Cañizo; Maria V Mateos; Jesús F San Miguel
Antibiotic prophylaxis with meropenem after allogeneic stem cell transplantation.
Bone marrow transplantation 2004;33(2):183-7.
2003: José Rodriguez; María Dolores Caballero; Antonio Gutierrez; Marcos Gandarillas; Jorge Sierra; Armando Lopez-Guillermo; Anna Sureda; Javier Zuazu; Jesus Marin; Reyes Arranz; Enric Carreras; Angel Leon; Alberto Fernández de Sevilla; Jesús F San Miguel; Eulogio Conde
High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experience.
Haematologica 2003;88(12):1372-7.
2003: Atanasio Pandiella; Xonia Carvajal-Vergara; Soraya Tabera; Gema Mateo; Norma C Gutiérrez; Jesús F San Miguel
Imatinib mesylate (STI571) inhibits multiple myeloma cell proliferation and potentiates the effect of common antimyeloma agents.
British journal of haematology 2003;123(5):858-68.
2003: María B Vidriales; Jesús F San Miguel; Alberto Orfao; Elaine Coustan-Smith; Dario Campana
Minimal residual disease monitoring by flow cytometry.
Best practice & research. Clinical haematology 2003;16(4):599-612.
2003: Maria Luz Sanchez; Julia Almeida; David Gonzalez; Marcos Gonzalez; Maria-Antonia Garcia-Marcos; Ana Balanzategui; Maria-Consuelo Lopez-Berges; Josep Nomdedeu; Teresa Vallespi; Marcos Barbon; Alejandro Martin; Pilar de la Fuente; Guillermo Martin-Nuñez; Javier Fernandez-Calvo; Jesus M Hernandez; Jesús F San Miguel; Alberto Orfao
Incidence and clinicobiologic characteristics of leukemic B-cell chronic lymphoproliferative disorders with more than one B-cell clone.
Blood 2003;102(8):2994-3002.
2003: Juan L García; Jesus M Hernandez; Norma C Gutiérrez; Teresa Flores; David González; María J Calasanz; José A Martínez-Climent; Miguel A Piris; C Lopéz-Capitán; M Belén González; María D Odero; Jesús F San Miguel
Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt's lymphoma. A cytogenetic and comparative genomic hybridization study.
Leukemia 2003;17(10):2016-24.
2003: Juan L Garcia; Jaime Font de Mora; Jesus M Hernandez; Jose A Queizan; Norma C Gutierrez; Jesus M Hernandez; Jesús F San Miguel
Imatinib mesylate elicits positive clinical response in atypical chronic myeloid leukemia involving the platelet-derived growth factor receptor beta.
Blood 2003;102(7):2699-700.
2003: Gema Mateo; Mercedes Corral; Julia Almeida; Consuelo López-Berges; maría Jesús Nieto; Antonia García-Marcos; Lourdes Vázquez; Consuelo del Cañizo; Alberto Orfao; Jesús F San Miguel
Immunophenotypic analysis of peripheral blood stem cell harvests from patients with multiple myeloma.
Haematologica 2003;88(9):1013-21.
2003: María-Belén Vidriales; Alberto Orfao; Jesús F San Miguel
Immunologic monitoring in adults with acute lymphoblastic leukemia.
Current oncology reports 2003;5(5):413-8.
2003: Margarida Lima; Julia Almeida; Maria dos Anjos Teixeira; Maria del Carmen Alguero Md; Ana Helena Santos; Ana Balanzategui; Maria Luís Queirós; Paloma Bárcena; Antonio Izarra; Sónia Fonseca; Clara Bueno; Benvindo Justiça; Marcos Gonzalez; Jesús F San Miguel; Alberto Orfao
TCRalphabeta+/CD4+ large granular lymphocytosis: a new clonal T-cell lymphoproliferative disorder.
The American journal of pathology 2003;163(2):763-71.
2003: María-Belén Vidriales; José J Pérez; Ma Consuelo López-Berges; Norma C Gutiérrez; Juana Ciudad; Paulo Lucio; Lourdes Vazquez; Ramón García-Sanz; Maria Consuelo Del Cañizo; Javier Fernández-Calvo; Fernando Ramos; M Jesús Rodríguez; M José Calmuntia; Ana Porwith; Alberto Orfao; Jesús F San Miguel
Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: early immunophenotypic evaluation has high clinical value.
Blood 2003;101(12):4695-700.
2003: Daniel Primo; María Dolores Tabernero; Ana Rasillo; José María Sayagués; Ana Belén Espinosa; M Carmen Chillón; R Garcia-Sanz; Norma C Gutierrez; M Giralt; A Hagemeijer; Jesús F San Miguel; Alberto Orfao
Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
Leukemia 2003;17(6):1124-9.
2003: David González; Marcos González; M E Alonso; Ricardo López-Pérez; Ana Balanzategui; M Carmen Chillón; M Silva; Ramón García-Sanz; Jesús F San Miguel
Incomplete DJH rearrangements as a novel tumor target for minimal residual disease quantitation in multiple myeloma using real-time PCR.
Leukemia 2003;17(6):1051-7.
2003: Jesús F San Miguel; Ramón García-Sanz
Myeloma: update on supportive care strategies.
Current treatment options in oncology 2003;4(3):247-58.
2003: Jesús F San Miguel; María-Belén Vidriales; Enrique M Ocio; Gema Mateo; F Sánchez-Guijo; María Luz Sánchez; Luis Escribano; Abelardo Bárez; María Jesús Moro; José Hernández; C Aguilera; R Cuello; J García-Frade; R López; Juan A Portero; Alberto Orfao
Immunophenotypic analysis of Waldenstrom's macroglobulinemia.
Seminars in oncology 2003;30(2):187-95.
2003: Roger G Owen; Steve P Treon; Ayad Al-Katib; Rafael Fonseca; Philip R Greipp; Mary L McMaster; Enrica Morra; Gerassimos A Pangalis; Jesús F San Miguel; Andrew R Branagan; Meletios A Dimopoulos
Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Seminars in oncology 2003;30(2):110-5.
2003: Maria Consuelo Del Cañizo; Ma Eugenia Fernández; Antonio López; Belén Vidriales; Eva Villarón; Jose Luis Arroyo; Francisco Ortuño; Alberto Orfao; Jesús F San Miguel
Immunophenotypic analysis of myelodysplastic syndromes.
Haematologica 2003;88(4):402-7.
2003: José A Pérez-Simón; Rodrigo Martino; Adrián Alegre; José F Tomás; Angel De Leon; Dolores Caballero; Anna Sureda; Jorge Sierra; Jesús F San Miguel
Chronic but not acute graft-versus-host disease improves outcome in multiple myeloma patients after non-myeloablative allogeneic transplantation.
British journal of haematology 2003;121(1):104-8.
2003: David Valcárcel; Rodrigo Martino; Dolores Caballero; Maria V Mateos; José A Pérez-Simón; Carme Canals; F Fernández; Joan Bargay; Eduardo Muñiz-Díaz; M Gonzalez; Jesús F San Miguel; Jorge Sierra
Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning.
Bone marrow transplantation 2003;31(5):387-92.
2003: Ana Rasillo; María Dolores Tabernero; María Luz Sánchez; Martín Pérez de Andrés; Marta Martín-Ayuso; José Hernández; María Jesús Moro; Javier Fernández-Calvo; José María Sayagués; Aglae Bortoluci; Jesús F San Miguel; Alberto Orfao
Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
Cancer 2003;97(3):601-9.
2003: Norma C Gutiérrez; Jordi Camps; Jesús M Hernández; Juan L García; Esther Prat; M Belén González; Rosa Miró; Jesús F San Miguel
Multicolor fluorescence in situ hybridization studies in multiple myeloma and monoclonal gammopathy of undetermined significance.
The hematology journal : the official journal of the European Haematology Association / EHA 2003;4(1):67-70.
2003: María Dolores Caballero; José A Pérez-Simón; Arturo Iriondo; Juan José Lahuerta; Jorge Sierra; Julián Marín; Marcos Gandarillas; Reyes Arranz; Javier Zuazu; V Rubio; Alberto Fernández de Sevilla; Enric Carreras; Javier García Conde; José García-Laraña; Carlos Grande; Anna Sureda; María J Vidal; J Rifón; C Pérez-Equiza; R Varela; José María Moraleda; J C García Ruíz; Carmen Albó; Rafael Cabrera; Jesús F San Miguel; Eulogio Conde
High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(1):140-51.
2002: José Ramón González-Porras; M González; Ramón García-Sanz; Jesús F San Miguel
Thalidomide in combination with cyclophosphamide and dexamethasone (thacydex) is effective in soft-tissue plasmacytomas.
British journal of haematology 2002;119(3):883-4.
2002: José A Pérez-Simón; panos kottaridis; Rodrigo Martino; Charles Craddock; Dolores Caballero; Rajesh Chopra; Javier García Conde; Donald W Milligan; Steve Schey; Alvaro Urbano-Ispizua; Anne Parker; Angel Leon; Kwee Yong; Anna Sureda; Ann Hunter; Jordi Sierra; Anthony H Goldstone; David C Linch; Jesús F San Miguel; Stephen Mackinnon
Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders.
Blood 2002;100(9):3121-7.
2002: Pablo Menéndez; José A Pérez-Simón; Maria V Mateos; María Dolores Caballero; Marcos González; Jesús F San Miguel; Alberto Orfao
Influence of the different CD34+ and CD34- cell subsets infused on clinical outcome after non-myeloablative allogeneic peripheral blood transplantation from human leucocyte antigen-identical sibling donors.
British journal of haematology 2002;119(1):135-43.
2002: Pablo Menéndez; María Dolores Caballero; Felipe Prosper; Maria Consuelo Del Cañizo; José A Pérez-Simón; Maria V Mateos; Maria J Nieto; Mercedes Corral; Mercedes Romero; Javier García Conde; Maria A Montalbán; Jesús F San Miguel; Alberto Orfao
The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen.
Transfusion 2002;42(9):1159-72.
2002: Maria V Mateos; Ramón García-Sanz; Ricardo López-Pérez; María Jesús Moro; Enrique M Ocio; José Hernández; Marta Megido; María Dolores Caballero; Javier Fernández-Calvo; Abelardo Bárez; Julia Almeida; Alberto Orfão; Marcos González; Jesús F San Miguel
Methylation is an inactivating mechanism of the p16 gene in multiple myeloma associated with high plasma cell proliferation and short survival.
British journal of haematology 2002;118(4):1034-40.
2002: Rodrigo Martino; Granada Perea; María Dolores Caballero; Maria V Mateos; Josep-Maria Ribera; Jaime Pérez de Oteyza; Reyes Arranz; María José Terol; Jorge Sierra; Jesús F San Miguel
Cyclophosphamide, pegylated liposomal doxorubicin (Caelyx), vincristine and prednisone (CCOP) in elderly patients with diffuse large B-cell lymphoma: results from a prospective phase II study.
Haematologica 2002;87(8):822-7.
2002: María Luz Sánchez; Julia Almeida; Belén Vidriales; Ma Consuelo López-Berges; María Antonia García-Marcos; María Jesús Moro; A Corrales; M José Calmuntia; Jesús F San Miguel; Alberto Orfao
Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Leukemia 2002;16(8):1460-9.
2002: José A Pérez-Simón; Dolores Caballero; Maria Diez-Campelo; R Lopez-Pérez; G Mateos; Consuelo Cañizo; Lourdes Vazquez; Belén Vidriales; Maria V Mateos; M Gonzalez; Jesús F San Miguel
Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation.
Leukemia 2002;16(8):1423-31.
2002: Alejandro Martín; Ramón García-Sanz; José Hernández; Joan Bladé; Begoña Suquía; Javier Fernández-Calvo; Marcos González; Gema Mateo; Alberto Orfao; Jesús F San Miguel
Pamidronate induces bone formation in patients with smouldering or indolent myeloma, with no significant anti-tumour effect.
British journal of haematology 2002;118(1):239-42.
2002: Maria I González-Fraile; Ramón García-Sanz; Maria V Mateos; Ana Balanzategui; Marcos González; Lourdes Váquez; Jesús F San Miguel
Methylenetetrahydrofolate reductase genotype does not play a role in multiple myeloma pathogenesis.
British journal of haematology 2002;117(4):890-2.
2002: Jesús F San Miguel; María B Vidriales; Alberto Orfão
Immunological evaluation of minimal residual disease (MRD) in acute myeloid leukaemia (AML).
Best practice & research. Clinical haematology 2002;15(1):105-18.
2002: Jesús F San Miguel; Julia Almeida; Gema Mateo; Joan Bladé; Consuelo López-Berges; Dolores Caballero; José Hernández; María Jesús Moro; Javier Fernández-Calvo; Joaquín Díaz-Mediavilla; Luis Palomera; Alberto Orfao
Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: a tool for comparing the efficacy of different treatment strategies and predicting outcome.
Blood 2002;99(5):1853-6.
2002: Josep-Maria Ribera; Juan J Ortega; Albert Oriol; Isabel Granada; Jesús-María Hernández-Rivas; Ricardo Parody; Concepción Bethencourt; Concepción Rivas; Pilar Bastida; Eloy del Potro; Maria-Elvira González-Valentín; María-José Moreno; Joan Besalduch; Javier Fernández-Calvo; Mar Tormo; Jesús Arias; Antonio Molinés; Miguel A Sanz; Juan Maldonado; Fuensanta Millá; Evarist Feliu; Jesús F San Miguel
Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Haematologica 2002;87(2):154-66.
2002: Ramón García-Sanz; Maria Isabel González-Fraile; Magdalena Sierra; Carlos López; Marcos González; Jesús F San Miguel
The combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is feasible and can be an option for relapsed/refractory multiple myeloma.
The hematology journal : the official journal of the European Haematology Association / EHA 2002;3(1):43-8.
2001: M González; Ricardo López-Pérez; Ramón García-Sanz; José A Pérez-Simón; Jesús F San Miguel
Debate round-table: comments concerning chimerism studies.
Leukemia 2001;15(12):1986-8.
2001: Lilia Suárez; B Vidriales; José García-Laraña; Antonio López; Rafael Martínez; V Martín-Reina; Mar Tormo; JD González-San Miguel; Esperanza Lavilla; Raimundo García-Boyero; Alberto Orfao; Jesús F San Miguel
Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia.
Haematologica 2001;86(12):1287-95.
2001: Margarida Lima; Julia Almeida; Ana Helena Santos; Maria dos Anjos Teixeira; M C Alguero; Maria Luís Queirós; Ana Balanzategui; Benvindo Justiça; Marcos Gonzalez; Jesús F San Miguel; Alberto Orfão
Immunophenotypic analysis of the TCR-Vbeta repertoire in 98 persistent expansions of CD3(+)/TCR-alphabeta(+) large granular lymphocytes: utility in assessing clonality and insights into the pathogenesis of the disease.
The American journal of pathology 2001;159(5):1861-8.
2001: Ricardo López-Pérez; Ramón García-Sanz; David González; Ana Balanzategui; M Carmen Chillón; I Alaejos; Maria V Mateos; María Dolores Caballero; Mercedes Corral; Alberto Orfão; Marcos González; Jesús F San Miguel
Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation.
Bone marrow transplantation 2001;28(7):665-72.
2001: Jose Luis Arroyo; María Antonia García-Marcos; Antonio López; Pablo Menéndez; María Dolores Tabernero; Luis Ignacio Sánchez-Abarca; C Avila-Zarza; Jesús F San Miguel; Alberto Orfao
Evaluation of a CD61 MoAb method for enumeration of platelets in thrombocytopenic patients and its impact on the transfusion decision-making process.
Transfusion 2001;41(10):1212-6.
2001: Jesús F San Miguel; María-Belén Vidriales; Consuelo López-Berges; Joaquín Díaz-Mediavilla; Norma C Gutiérrez; Consuelo Cañizo; Fernando Ramos; M José Calmuntia; José J Pérez; Marcos González; Alberto Orfao
Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification.
Blood 2001;98(6):1746-51.
2001: Paulo Lucio; G Gaipa; Ellen G van Lochem; Elisabeth R van Wering; Anna Porwit-MacDonald; T Faria; E Bjorklund; A Biondi; MW Van den Beemd; EA Baars; B Vidriales; Antonio Parreira; Jacques J M van Dongen; Jesús F San Miguel; Alberto Orfao
BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical Evaluation.
Leukemia 2001;15(8):1185-92.
2001: Juan J Ortega; Josep-Maria Ribera; Albert Oriol; Pilar Bastida; M E González; C Calvo; I Egurbide; Jesús-María Hernández-Rivas; Concepción Rivas; Antonio Alcalá; Joan Besalduch; J Maciá; Santiago Gardella; M Carnero; J M Lite; F Casanova; M Martinez; Montserrat Fontanillas; Evarist Feliu; Jesús F San Miguel
Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL.
Haematologica 2001;86(6):586-95.
2001: Miguel A Canales; MC Fernández-Jiménez; Alejandro Martín; Rosario Arrieta; María Dolores Caballero; J Díez; Evaristo Quevedo; J García Bustos; Jesús F San Miguel; Fernando Hernández-Navarro
Identification of factors associated with poor peripheral blood progenitor cell mobilization in Hodgkin's disease.
Haematologica 2001;86(5):494-8.
2001: Norma C Gutiérrez; Jesús M Hernández; Juan L García; MC Cañizo; Marcos González; José Hernández; M Belén González; M A Garciá-Marcos; Jesús F San Miguel
Differences in genetic changes between multiple myeloma and plasma cell leukemia demonstrated by comparative genomic hybridization.
Leukemia 2001;15(5):840-5.
2001: Jesús M Hernández; Juan L García; Norma C Gutiérrez; Manuela Mollejo; José A Martínez-Climent; Teresa Flores; M Belén González; Miguel A Piris; Jesús F San Miguel
Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics.
The American journal of pathology 2001;158(5):1843-50.
2001: Alejandro Martín; MC Fernández-Jiménez; María Dolores Caballero; Miguel A Canales; José A Pérez-Simón; J García de Bustos; Lourdes Vázquez; Fernando Hernández-Navarro; Jesús F San Miguel
Long-term follow-up in patients treated with Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease.
British journal of haematology 2001;113(1):161-71.
2001: M I González-Fraile; Consuelo Cañizo; Dolores Caballero; R Hernández; Lourdes Vázquez; C López; A Izarra; Jose Luis Arroyo; A de la Loma; M J Otero; Jesús F San Miguel
Cidofovir treatment of human polyomavirus-associated acute haemorrhagic cystitis.
Transplant infectious disease : an official journal of the Transplantation Society 2001;3(1):44-6.
2001: P Menéndez; Felipe Prósper; C Bueno; Cristina Arbona; Jesús F San Miguel; Javier García Conde; C Solá; Javier Hornedo; Hernán Cortés-Funes; Alberto Orfao
Sequential analysis of CD34+ and CD34- cell subsets in peripheral blood and leukapheresis products from breast cancer patients mobilized with SCF plus G-CSF and cyclophosphamide.
Leukemia 2001;15(3):430-9.
2001: María Dolores Tabernero; Aglae Bortoluci; I Alaejos; Ma Consuelo López-Berges; Ana Rasillo; Ramón García-Sanz; M García; José María Sayagués; Marcos González; Gema Mateo; Jesús F San Miguel; Alberto Orfao
Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expresssion.
Leukemia 2001;15(3):406-14.
2001: C Bueno; Julia Almeida; Maria Carmen Alguero; María Luz Sánchez; José Miguel Vaquero; Francisco Javier Laso; Jesús F San Miguel; Luis Escribano; Alberto Orfao
Flow cytometric analysis of cytokine production by normal human peripheral blood dendritic cells and monocytes: comparative analysis of different stimuli, secretion-blocking agents and incubation periods.
Cytometry 2001;46(1):33-40.
2001: CM Chillón; Ramón García-Sanz; Ana Balanzategui; Fernando Ramos; Javier Fernández-Calvo; M J Rodríguez; M I Rodríguez-Salazar; A Corrales; M José Calmuntia; Alberto Orfão; Marcos González; Jesús F San Miguel
Molecular characterization of acute myeloblastic leukemia according to the new WHO classification: a different distribution in Central-West Spain.
Haematologica 2001;86(2):162-6.
2001: Joan Bladé; Jesús F San Miguel; Montserrat Fontanillas; Jordi Esteve; Juan Maldonado; Antonio Alcalá; Salut Brunet; Javier García Conde; Joan Besalduch; María Jesús Moro; Javier Fernández-Calvo; Eulogio Conde; Llorenç Font; Santiago Gardella; M Carnero; Félix Carbonell; Josep M Martí; J Hernández-Martín; F Ortega; Carles Besses; Josep-Maria Ribera; Jesús Trujillo; M L Escudero; Ciril Rozman; Jordi Estapé; Emili Montserrat
Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patients.
The hematology journal : the official journal of the European Haematology Association / EHA 2001;2(4):272-8.
2001: Maria V Mateos; Ramon Garcia-Sanz; Ricardo López-Pérez; Ana Balanzategui; MI González; Javier Fernández-Calvo; María Jesús Moro; José Hernández; María Dolores Caballero; Marcos González; Jesús F San Miguel
p16/INK4a gene inactivation by hypermethylation is associated with aggressive variants of monoclonal gammopathies.
The hematology journal : the official journal of the European Haematology Association / EHA 2001;2(3):146-9.
2000: Jose Luis Arroyo; Norma C Gutierrez; María Antonia García-Marcos; R Villarroel; P Galindo; Ma Eugenia Fernández; A Izarra; Maria Consuelo Del Cañizo; María Dolores Caballero; Jesús F San Miguel
Monocyte counts: an early index of haemopoietic reconstitution after peripheral blood stem cell transplantation.
British journal of haematology 2000;111(3):987-9.
2000: R Hernández; Maria Consuelo Del Cañizo; C López; MI González; M L Vázquez; María Dolores Caballero; Jesús F San Miguel
Pathologic rupture of the spleen during induction with ATRA in a patient with acute promyelocytic leukemia.
Medical oncology (Northwood, London, England) 2000;17(4):337-9.
2000: Norma C Gutiérrez; Jesús M Hernández; Juan L García; Julia Almeida; Gema Mateo; MI González; José Hernández; Javier Fernández-Calvo; Jesús F San Miguel
Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma: monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells.
Haematologica 2000;85(11):1146-52.
2000: M I González; Dolores Caballero; C López; T Alburquerque; R Hernández; A de la Loma; Consuelo Cañizo; Lourdes Vázquez; Jesús F San Miguel
Cerebral toxoplasmosis and Guillain-Barré syndrome after allogeneic peripheral stem cell transplantation.
Transplant infectious disease : an official journal of the Transplantation Society 2000;2(3):145-9.
2000: Ricardo López-Pérez; Ramón García-Sanz; David González; Ana Balanzategui; M Carmen Chillón; I Alaejos; Maria V Mateos; María Dolores Caballero; Gema Mateo; Maria J Nieto; Marcos González; Jesús F San Miguel
The detection of contaminating clonal cells in apheresis products is related to response and outcome in multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
Leukemia 2000;14(8):1493-9.
2000: Maria V Mateos; Marcos González; Ana Balanzategui; Ricardo López-Pérez; David González; M Carmen Chillón; I Alaejos; Ramón García-Sanz; Jesús F San Miguel
Status of methylation of p16 gene in multiple myeloma: a comparative study of three methods for its detection.
Clinical biochemistry 2000;33(5):415-8.
2000: M I González; Dolores Caballero; Lourdes Vázquez; Consuelo Cañizo; R Hernández; C López; A Izarra; Jose Luis Arroyo; Marcos González; R García; Jesús F San Miguel
Allogeneic peripheral stem cell transplantation in a case of hereditary sideroblastic anaemia.
British journal of haematology 2000;109(3):658-60.
2000: Anna Porwit-MacDonald; Elisabet Björklund; Paulo Lucio; Ellen G van Lochem; Joanna Mazur; Antonio Parreira; MW Van den Beemd; Elisabeth R van Wering; EA Baars; G Gaipa; A Biondi; Juana Ciudad; Jacques J M van Dongen; Jesús F San Miguel; Alberto Orfao
BIOMED-1 concerted action report: flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL).
Leukemia 2000;14(5):816-25.
2000: J M Hernández; Maria Consuelo Del Cañizo; A Cuneo; J L García; Norma C Gutiérrez; M González; G Castoldi; Jesús F San Miguel
Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(4):441-4.
2000: Lourdes Vazquez; Dolores Caballero; Consuelo Cañizo; C Lopez; R Hernandez; I Gonzalez; Teresa Flores; Jesús F San Miguel
Allogeneic peripheral blood cell transplantation for hypereosinophilic syndrome with myelofibrosis.
Bone marrow transplantation 2000;25(2):217-8.
2000: Marcos González; Maria V Mateos; Ramón García-Sanz; Ana Balanzategui; Ricardo López-Pérez; M Carmen Chillón; David González; I Alaejos; Jesús F San Miguel
De novo methylation of tumor suppressor gene p16/INK4a is a frequent finding in multiple myeloma patients at diagnosis.
Leukemia 2000;14(1):183-7.
2000: Jesús M Hernández; M Belén González; Juan L García; M Teresa Ferro; Norma C Gutiérrez; P Marynen; Jesús F San Miguel
Two cases of myeloid disorders and a t(8;12) (q12;p13).
Haematologica 2000;85(1):31-4.
1999: Jesús F San Miguel; Juana Ciudad; María-Belén Vidriales; Alberto Orfao; Paulo Lucio; A Porwit-MacDonald; G Gaipa; E van Wering; Jacques J M van Dongen
Immunophenotypical detection of minimal residual disease in acute leukemia.
Critical reviews in oncology/hematology 1999;32(3):175-85.
1999: José A Pérez-Simón; Alejandro Martín; Dolores Caballero; Mercedes Corral; Maria J Nieto; M Gonzalez; Lourdes Vazquez; Consuelo López-Berges; MC Cañizo; Maria V Mateos; Alberto Orfao; Jesús F San Miguel
Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation.
Bone marrow transplantation 1999;24(12):1279-83.
1999: Consuelo del Cañizo; Josefina Galende; Julia Almeida; A Brufau; A Mota; Jesús F San Miguel
In vitro growth in acute myeloblastic leukemia: clinico-biological correlations.
Leukemia & lymphoma 1999;36(1-2):1-7.
1999: Julia Almeida; C Bueno; Maria Carmen Alguero; Maria Luz Sanchez; M C Cañizo; ME Fernandez; José Miguel Vaquero; Francisco Javier Laso; Luis Escribano; Jesús F San Miguel; Alberto Orfao
Extensive characterization of the immunophenotype and pattern of cytokine production by distinct subpopulations of normal human peripheral blood MHC II+/lineage- cells.
Clinical and experimental immunology 1999;118(3):392-401.
1999: Ramón García-Sanz; I Alaejos; Alberto Orfão; Ana Rasillo; M Carmen Chillón; María Dolores Tabernero; Maria V Mateos; Ricardo López-Pérez; David González; Ana Balanzategui; Marcos González; Jesús F San Miguel; A Bortolucci
Low frequency of the TEL/AML1 fusion gene in acute lymphoblastic leukaemia in Spain.
British journal of haematology 1999;107(3):667-9.
1999: Julia Almeida; Alberto Orfao; M Ocqueteau; Gema Mateo; Mercedes Corral; María Dolores Caballero; J Blade; María Jesús Moro; Jose Hernandez; Jesús F San Miguel
High-sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myeloma.
British journal of haematology 1999;107(1):121-31.
1999: Alberto Orfao; G Schmitz; Bruno Brando; A Ruiz-Arguelles; G Basso; R Braylan; G Rothe; Francis Lacombe; F Lanza; S Papa; Paulo Lucio; Jesús F San Miguel
Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions.
Clinical chemistry 1999;45(10):1708-17.
1999: Marcos González; David González; Ricardo López-Pérez; Ramón García-Sanz; M Carmen Chillón; Ana Balanzategui; Maria V Mateos; I Alaejos; Anton Langerak; Alberto Orfão; J J Van Dongen; Jesús F San Miguel
Heteroduplex analysis of VDJ amplified segments from rearranged IgH genes for clonality assessments in B-cell non-Hodgkin's lymphoma. A comparison between different strategies.
Haematologica 1999;84(9):779-84.
1999: Juan L García; Norma C Gutiérrez; Jesús M Hernández; M A Sánchez; M Belén González; Jose Luis Arroyo; Jesús F San Miguel
[Comparative genomic hybridization. Methodologic features].
Sangre 1999;44(4):291-6.
1999: Beatriz Díaz-Agustín; Luis Escribano; Pilar Bravo; Sonia Herrero; R Nuñez; R Navalón; L Navarro; Antonio Torrelo; A Cantalapiedra; L Del Castillo; Jesus Villarrubia; José L Navarro; Jesús F San Miguel; Alberto Orfao
The CD69 early activation molecule is overexpressed in human bone marrow mast cells from adults with indolent systemic mast cell disease.
British journal of haematology 1999;106(2):400-5.
1999: M f Amigo; Maria Consuelo Del Cañizo; María Dolores Caballero; Lourdes Vazquez; Mercedes Corral; Belén Vidriales; A Brufau; Jesús F San Miguel
Factors that influence long-term hematopoietic function following autologous stem cell transplantation.
Bone marrow transplantation 1999;24(3):289-93.
1999: M f Amigo; Maria Consuelo Del Cañizo; A Rios; M A Garcia; María Dolores Caballero; A Martin; N Bermejo; P Vilches; Jesús F San Miguel
Diagnosis of secondary myelodysplastic syndromes (MDS) following autologous transplantation should not be based only on morphological criteria used for diagnosis of de novo MDS.
Bone marrow transplantation 1999;23(10):997-1002.
1999: Consuelo del Cañizo; N Lopez; Dolores Caballero; E Fernandez; A Brufau; Lourdes Vazquez; V Mateos; Norma C Gutierrez; Jesús F San Miguel
Haematopoietic damage persists 1 year after autologous peripheral blood stem cell transplantation.
Bone marrow transplantation 1999;23(9):901-5.
1999: Alberto Orfao; M Carmen Chillón; Aglae Bortoluci; Ma Consuelo López-Berges; Ramón García-Sanz; Marcos Gonzalez; María Dolores Tabernero; María Antonia García-Marcos; Ana Rasillo; J Hernández-Rivas; Jesús F San Miguel
The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARalpha gene rearrangements.
Haematologica 1999;84(5):405-12.
1999: A Martínez; Jesús F San Miguel; María-Belén Vidriales; Juana Ciudad; María Dolores Caballero; Ma Consuelo López-Berges; María Jesús Moro; M José Calmuntia; F Ortega; Alberto Orfao
An abnormal CD34+ myeloid/CD34+ lymphoid ratio at the end of chemotherapy predicts relapse in patients with acute myeloid leukemia.
Cytometry 1999;38(2):70-5.
1999: Ramón García-Sanz; Ricardo López-Pérez; Anton Langerak; David González; M Carmen Chillón; Ana Balanzategui; Maria V Mateos; I Alaejos; Marcos González; J J Van Dongen; Jesús F San Miguel
Heteroduplex PCR analysis of rearranged immunoglobulin genes for clonality assessment in multiple myeloma.
Haematologica 1999;84(4):328-35.
1999: Juana Ciudad; Jesús F San Miguel; Ma Consuelo López-Berges; María Antonia García-Marcos; Marcos González; Lourdes Vázquez; Maria Consuelo Del Cañizo; Antonio López; Jacques J M van Dongen; Alberto Orfao
Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALL.
British journal of haematology 1999;104(4):695-705.
1999: Paulo Lucio; Antonio Parreira; MW Van den Beemd; Ellen G van Lochem; Elisabeth R van Wering; EA Baars; Anna Porwit-MacDonald; E Bjorklund; G Gaipa; A Biondi; Alberto Orfao; G Janossy; Jacques J M van Dongen; Jesús F San Miguel
Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL.
Leukemia 1999;13(3):419-27.
1999: C Cerveró; Luis Escribano; Jesús F San Miguel; Beatriz Díaz-Agustín; Pilar Bravo; Jesus Villarrubia; Ramón García-Sanz; JL Velasco; Pilar Herrera; M Vargas; M González; José L Navarro; Alberto Orfao
Expression of Bcl-2 by human bone marrow mast cells and its overexpression in mast cell leukemia.
American journal of hematology 1999;60(3):191-5.
1999: José A Pérez-Simón; B Valverde; A Martínez; D Tabernero; Julia Almeida; Norma C Gutierrez; Jesús F San Miguel; Alberto Orfao
Correlation of rhodamine 123 efflux by neoplastic plasma cells with clinical and biological characteristics of multiple myeloma.
Cytometry 1999;38(1):24-9.
1999: Julia Almeida; Alberto Orfao; Gema Mateo; M Ocqueteau; Ramón García-Sanz; María Jesús Moro; Jose Hernandez; F Ortega; D Borrego; Abelardo Barez; M Mejido; Jesús F San Miguel
Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance.
Pathologie-biologie 1999;47(2):119-27.
1999: Jesús F San Miguel; J Bladé Creixenti; Ramón García-Sanz
Treatment of multiple myeloma.
Haematologica 1999;84(1):36-58.
1998: Pablo Menéndez; O Redondo; A Rodriguez; Maria-Consuelo Lopez-Berges; G Ercilla; Antonio López; A Durán; Julia Almeida; José A Pérez-Simón; Jesús F San Miguel; J W Gratama; Alberto Orfao
Comparison between a lyse-and-then-wash method and a lyse-non-wash technique for the enumeration of CD34+ hematopoietic progenitor cells.
Cytometry 1998;34(6):264-71.
1998: Juana Ciudad; Alberto Orfao; Belén Vidriales; Ana Macedo; A Martínez; Marcos González; Ma Consuelo López-Berges; B Valverde; Jesús F San Miguel
Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.
Haematologica 1998;83(12):1069-75.
1998: Juana Ciudad; Jesús F San Miguel; Ma Consuelo López-Berges; Belén Vidriales; B Valverde; M Ocqueteau; G Mateos; María Dolores Caballero; José Hernández; María Jesús Moro; Maria V Mateos; Alberto Orfao
Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(12):3774-81.
1998: Luis Escribano; Alberto Orfao; Beatriz Díaz-Agustín; C Cerveró; Sonia Herrero; Jesus Villarrubia; Pilar Bravo; Antonio Torrelo; T Montero; M Valdemoro; JL Velasco; José L Navarro; Jesús F San Miguel
Human bone marrow mast cells from indolent systemic mast cell disease constitutively express increased amounts of the CD63 protein on their surface.
Cytometry 1998;34(5):223-8.
1998: J M Hernández; Norma C Gutiérrez; J Almeida; J L García; M A Sánchez; Gema Mateo; A Ríos; Jesús F San Miguel
IL-4 improves the detection of cytogenetic abnormalities in multiple myeloma and increases the proportion of clonally abnormal metaphases.
British journal of haematology 1998;103(1):163-7.
1998: Maria Consuelo Del Cañizo; A Brufau; Julia Almeida; Josefina Galende; María Antonia García-Marcos; A Mota; R García; Javier Fernández-Calvo; Fernando Ramos; P Fisac; Alberto Orfao; Jesús F San Miguel
In vitro growth in acute myeloblastic leukaemia: relationship with other clinico-biological characteristics of the disease.
British journal of haematology 1998;103(1):137-42.
1998: M f Amigo; Maria Consuelo Del Cañizo; Jesús M Hernández; M B Gonzalez; Norma C Gutiérrez; Maria V Mateos; Jesús F San Miguel
Clonal myelodysplastic cells present in apheresis product before transplantation.
Leukemia 1998;12(9):1497-9.
1998: Jesús F San Miguel; R García-Sanz
Recombinant human erythropoietin in the anaemia of multiple myeloma and non-Hodgkin's lymphoma.
Medical oncology (Northwood, London, England) 1998;15 Suppl 1():S29-34.
1998: Luis Escribano; M Ocqueteau; Julia Almeida; Alberto Orfao; Jesús F San Miguel
Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis.
Leukemia & lymphoma 1998;30(5-6):459-66.
1998: Joan Bladé; Jesús F San Miguel; M L Escudero; Montserrat Fontanillas; Joan Besalduch; Santiago Gardella; J Arias; Javier García Conde; M Carnero; J M Marti; Ciril Rozman; Jordi Estapé; Emili Montserrat
Maintenance treatment with interferon alpha-2b in multiple myeloma: a prospective randomized study from PETHEMA (Program for the Study and Treatment of Hematological Malignancies, Spanish Society of Hematology).
Leukemia 1998;12(7):1144-8.
1998: M D Hernández; Maria Consuelo Del Cañizo; Marcos González; M D Caballero; Ma Consuelo López-Berges; L Vázquez; Alberto Orfao; M Corral; Maria J Nieto; Jesús F San Miguel
[Immune reconstitution after autologous progenitor hemopoietic cell transplantation. A study comparing autologous bone marrow and autologous peripheral blood transplantation].
Medicina clínica 1998;110(20):768-73.
1998: María Dolores Caballero; Lourdes Vazquez; J M Barragan; J J Cruz; A Gomez; Maria J Nieto; Mercedes Corral; E Fonseca; Jesús F San Miguel
Randomized study of filgrastim versus molgramostim after peripheral stem cell transplant in breast cancer.
Haematologica 1998;83(6):514-8.
1998: M Ocqueteau; Alberto Orfao; Julia Almeida; Joan Bladé; Marcos González; Ramón García-Sanz; Consuelo López-Berges; María Jesús Moro; José Hernández; Luis Escribano; Dolores Caballero; M Rozman; Jesús F San Miguel
Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
The American journal of pathology 1998;152(6):1655-65.
1998: Francisco Javier Laso; M C Iglesias; Antonio López; Juana Ciudad; Jesús F San Miguel; Alberto Orfao
Increased interleukin-12 serum levels in chronic alcoholism.
Journal of hepatology 1998;28(5):771-7.
1998: José A Pérez-Simón; Ramón García-Sanz; María Dolores Tabernero; Julia Almeida; Marcos González; Javier Fernández-Calvo; María Jesús Moro; Jesús M Hernández; Jesús F San Miguel; Alberto Orfão
Prognostic value of numerical chromosome aberrations in multiple myeloma: A FISH analysis of 15 different chromosomes.
Blood 1998;91(9):3366-71.
1998: José A Pérez-Simón; María Dolores Caballero; Mercedes Corral; Maria J Nieto; Alberto Orfao; Lourdes Vazquez; M f Amigo; C Berges; Marcos González; Consuelo del Cañizo; Jesús F San Miguel
Minimal number of circulating CD34+ cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation.
Transfusion 1998;38(4):385-91.
1998: Josep-Maria Ribera; Juan J Ortega; Albert Oriol; Montserrat Fontanillas; Jesús-María Hernández-Rivas; Salut Brunet; Javier García Conde; Juan Maldonado; Javier Zuazu; Santiago Gardella; Joan Besalduch; P León; J Macià; A Domingo-Albós; Evarist Feliu; Jesús F San Miguel
Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology.
Haematologica 1998;83(3):222-30.
1998: Ramón García-Sanz; M Vargas Montero; M Gonzalez Díaz; M del Carmen; C Santos; A Balanzategui Echevarria; T Flores Corral; J M Hernández Martín; M D Caballero Barrigón; Jesús F San Miguel
Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype.
Haematologica 1998;83(3):209-16.
1998: Luis Escribano; Alberto Orfao; Jesus Villarrubia; Beatriz Díaz-Agustín; C Cerveró; A Rios; JL Velasco; J Ciudad; José L Navarro; Jesús F San Miguel
Immunophenotypic characterization of human bone marrow mast cells. A flow cytometric study of normal and pathological bone marrow samples.
Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 1998;16(3):151-9.
1998: Maria Consuelo Del Cañizo; A Brufau; A Mota; N Lopez; ME Fernandez; Carlos Vallejo; Jesus M Hernandez; Juan Luis Garcia; Jesús F San Miguel
The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders.
Haematologica 1998;83(1):3-7.
1997: Ramón García-Sanz; Marcos González; M Vargas; M Carmen Chillón; Ana Balanzategui; M Barbón; M T Flores; Jesús F San Miguel
Deletions and rearrangements of cyclin-dependent kinase 4 inhibitor gene p16 are associated with poor prognosis in B cell non-Hodgkin's lymphomas.
Leukemia 1997;11(11):1915-20.
1997: C Vallejo; M D Caballero; Ramón García-Sanz; Jesús M Hernández; L Vázquez; MC Cañizo; Josefina Galende; C I Colino; A Gil-Hurlé; Jesús F San Miguel
Sequential intravenous-oral ciprofloxacin plus amoxycillin/clavulanic acid shortens hospital stay in infected non severe neutropenic patients.
Hematology and cell therapy 1997;39(5):223-7.
1997: Francisco Javier Laso; P Lapeña; JI Madruga; Jesús F San Miguel; Alberto Orfao; M C Iglesias; M Alvarez-Mon
Alterations in tumor necrosis factor-alpha, interferon-gamma, and interleukin-6 production by natural killer cell-enriched peripheral blood mononuclear cells in chronic alcoholism: relationship with liver disease and ethanol intake.
Alcoholism, clinical and experimental research 1997;21(7):1226-31.
1997: Carlos Vallejo; María Antonia García-Marcos; Maria Consuelo Del Cañizo; Alberto Orfao; Julia Almeida; Luis Escribano; Jesús F San Miguel; A Ríos
[Syndrome of abnormal chromatin clumping in leucocytes with a high fraction of bone marrow cells in S-phase and in vitro autonomous growth].
Medicina clínica 1997;109(9):340-2.
1997: Jesús F San Miguel; A Martínez; Ana Macedo; María-Belén Vidriales; Consuelo López-Berges; Marcos González; Dolores Caballero; María Antonia García-Marcos; Fernando Ramos; Javier Fernández-Calvo; M José Calmuntia; J Diaz-Mediavilla; Alberto Orfao
Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients.
Blood 1997;90(6):2465-70.
1997: M f Amigo; María Dolores Caballero; Lourdes Vazquez; Teresa Flores; Antonio López; Jesús F San Miguel
Immune thrombocytopenic purpura secondary to endometriosis.
Haematologica 1997;82(5):602-3.
1997: M García-Isidoro; María Dolores Tabernero; Maria Luisa Najera; Juan L García; Jesus M Hernandez; Angel Duran; Jesús F San Miguel; Alberto Orfao
Clinical and biological characteristics of myelodysplastic syndromes with nulisomy Y by fish.
Haematologica 1997;82(5):537-41.
1997: A Martínez; Jesús F San Miguel; B Valverde; Abelardo Bárez; María Jesús Moro; María Antonia García-Marcos; José A Pérez-Simón; Belén Vidriales; Alberto Orfao
Functional expression of MDR-1 in acute myeloid leukemia: correlation with the clinical-biological, immunophenotypical, and prognostic disease characteristics.
Annals of hematology 1997;75(3):81-6.
1997: María Dolores Caballero; V Rubio; J Rifon; I Heras; Ramón García-Sanz; Lourdes Vázquez; Belén Vidriales; Maria Consuelo Del Cañizo; Mercedes Corral; M Gonzalez; Angel León; E Jean-Paul; E Rocha; José María Moraleda; Jesús F San Miguel
BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors.
Bone marrow transplantation 1997;20(6):451-8.
1997: Maria Consuelo Del Cañizo; Josefina Galende; A Mota; Alberto Orfao; A Martinez; Julia Almeida; Jesús F San Miguel
In leukemic hematopoiesis CD34 antigen does not have the same significance as it does normal hematopoiesis.
Leukemia research 1997;21(7):651-6.
1997: M Garcia-Isidoro; María Dolores Tabernero; Maria Luisa Najera; Maria-Consuelo Lopez-Berges; A Martinez; A Durán; Juan Luis Garcia; Jesus M Hernandez; M A Garcia Marcos; Jesús F San Miguel; Alberto Orfao
Association between trisomy 8 and the immunophenotype of blast cells from acute leukemias secondary to a myelodysplastic syndrome or chronic myeloproliferative disorders.
Annals of hematology 1997;74(5):209-14.
1997: Francisco Javier Laso; JI Madruga; J A Girón; Antonio López; Juana Ciudad; Jesús F San Miguel; M Alvarez-Mon; Alberto Orfao
Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption.
Hepatology (Baltimore, Md.) 1997;25(5):1096-100.
1997: Luis Escribano; Alberto Orfao; Jesus Villarrubia; F Martín; J I Madruga; M Cuevas; JL Velasco; A Rios; Jesús F San Miguel
Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia.
Cytometry 1997;30(2):98-102.
1997: Dolores Caballero; V Rubio; J Rifon; I Heras; Ramón García-Sanz; Belén Vidriales; José A Pérez-Simón; Consuelo del Cañizo; Marcos González; Angel León; E Jean-Paul; E Rocha; Vicente Vicente; Jesús F San Miguel
[Autologous transplant with BEAM protocol in lymphoma].
Sangre 1997;42 Suppl 1():46-9.
1997: L López; J A Portero; D Borrego; Abelardo Barez; Jesús F San Miguel
[High cardiac output in myeloma patients. Its prevalence and clinical characteristics. The Castile-León Cooperative Group for the Study of Monoclonal Gammapathies].
Medicina clínica 1997;108(6):214-6.
1997: María Dolores Caballero; M f Amigo; Jesús M Hernández; Lourdes Vazquez; Consuelo del Cañizo; M Gonzalez; R García; Jesús F San Miguel
Alternating mini-BEAM/ESHAP as salvage therapy for refractory non-Hodgkin's lymphomas.
Annals of hematology 1997;74(2):79-82.
1997: C Sanfructuoso; M D Caballero; L Vázquez; Josefina Galende; J Almeida; Jesús F San Miguel
Rhabdomyolysis associated with septicemia after autologous bone marrow transplantation.
Bone marrow transplantation 1997;19(1):95.
1996: Francisco Javier Laso; J I Madruga; Jesús F San Miguel; Juana Ciudad; Antonio López; Melchor Alvarez-Mon; Alberto Orfao
Long lasting immunological effects of ethanol after withdrawal.
Cytometry 1996;26(4):275-80.
1996: F Dolbeare; N Lopez; A Lopez; M f Amigo; Juana Ciudad; Maria Consuelo Del Cañizo; Jesús F San Miguel; Alberto Orfao
Multiparametric cell-cycle analysis of peripheral blood-activated lymphocyte subsets using staining based on the TdT method for incorporated BrdUrd.
Cytometry 1996;25(4):317-23.
1996: M Ocqueteau; Alberto Orfao; Ramón García-Sanz; Julia Almeida; M Gonzalez; Jesús F San Miguel
Expression of the CD117 antigen (c-Kit) on normal and myelomatous plasma cells.
British journal of haematology 1996;95(3):489-93.
1996: Alberto Orfao; Luis Escribano; Jesus Villarrubia; JL Velasco; C Cerveró; J Ciudad; J L Navarro; Jesús F San Miguel
Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples: identification and enumeration.
The American journal of pathology 1996;149(5):1493-9.
1996: N López Holgado; M Consuelo del Cañizo; M D Tabernero; M D Hernández; Carlos Vallejo; Jesús F San Miguel
[Long-term culture: evidence of the capacity of stroma to sustain hematopoiesis of a second inoculum].
Sangre 1996;41(5):345-9.
1996: Jesús F San Miguel; Ramón García-Sanz; Marcos González; Alberto Orfão
DNA cell content studies in multiple myeloma.
Leukemia & lymphoma 1996;23(1-2):33-41.
1996: M Ocqueteau; Jesús F San Miguel; Marcos González; Julia Almeida; Alberto Orfao
Do myelomatous plasma cells really express surface immunoglobulins?
Haematologica 1996;81(5):460-3.
1996: Marcos González; Ramón García-Sanz; M Vargas; Ana Balanzategui; M Carmen Chillón; Maria V Mateos; Jesús F San Miguel
[Molecular biology in malignant blood diseases. Clinical applications. Study of immunoglobulin and T-cell receptor genes and molecular analysis of the translocations].
Sangre 1996;41(4):321-34.
1996: Marcos González; Ramón García-Sanz; M C Chillon; Ana Balanzategui; M Vargas; M F García; Jesús F San Miguel
[Molecular biology in malignant blood diseases. Methodological aspects: Southern blotting techniques and the polymerase chain reaction].
Sangre 1996;41(4):311-9.
1996: Jesús F San Miguel; M D Hernández; M Gonzalez; Ma Consuelo López-Berges; María Dolores Caballero; Lourdes Vazquez; Alberto Orfao; Maria J Nieto; Mercedes Corral; Maria Consuelo Del Cañizo
A randomized study comparing the effect of GM-CSF and G-CSF on immune reconstitution after autologous bone marrow transplantation.
British journal of haematology 1996;94(1):140-7.
1996: D Tabernero; Jesús F San Miguel; M Garcia-Sanz; L Nájera; M García-Isidoro; J A Peréz-Simon; M Gonzalez; J Wiegant; A K Raap; Alberto Orfão
Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes.
The American journal of pathology 1996;149(1):153-61.
1996: Joan Bladé; Jesús F San Miguel; Montserrat Fontanillas; A Alcalá; J Maldonado; Javier García Conde; E Conde; G Conzález-Brito; M J Moro; M L Escudero; J Trujillo; A Pascual; Ciril Rozman; Jordi Estapé; Emili Montserrat
Survival of multiple myeloma patients who are potential candidates for early high-dose therapy intensification/ autotransplantation and who were conventionally treated.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(7):2167-73.
1996: Maria Consuelo Del Cañizo; A Mota; Alberto Orfao; Josefina Galende; María Dolores Caballero; M A Garcia Marcos; Jesús F San Miguel
Value of colony forming unit-granulocyte macrophage assay in predicting relapse in acute myeloid leukaemia.
Journal of clinical pathology 1996;49(6):450-2.
1996: Julia Almeida; M Consuelo Del Cañizo; Josefina Galende; Jesús F San Miguel
Responsiveness of AML cells to recombinant hematopoietic growth factors: relationship with morphological and immunological characteristics of blast cells.
Leukemia research 1996;20(6):533-4.
1996: Jesús F San Miguel; Guillermo F Sanz; T Vallespí; M C del Cañizo; M A Sanz
Myelodysplastic syndromes.
Critical reviews in oncology/hematology 1996;23(1):57-93.
1996: Ramón García-Sanz; Marcos González; Alberto Orfão; María Jesús Moro; Jesús M Hernández; D Borrego; M Carnero; F Casanova; A Bárez; R Jiménez; J A Portero; Jesús F San Miguel
Analysis of natural killer-associated antigens in peripheral blood and bone marrow of multiple myeloma patients and prognostic implications.
British journal of haematology 1996;93(1):81-8.
1996: C Sanfructuoso; María Dolores Caballero; R Garcia-Sanz; Belén Vidriales; Lourdes Vazquez; Jesús F San Miguel
Relapse of multiple myeloma in extramedullary sites after autologous bone marrow transplantation.
European journal of haematology 1996;56(3):181-3.
1996: A Macedo; Jesús F San Miguel; María-Belén Vidriales; Ma Consuelo López-Berges; María Antonia García-Marcos; M Gonzalez; C Landolfi; Alberto Orfão
Phenotypic changes in acute myeloid leukaemia: implications in the detection of minimal residual disease.
Journal of clinical pathology 1996;49(1):15-8.
1995: M f Amigo; R Revilla; C Sánchez; Consuelo del Cañizo; Dolores Caballero; Jesús F San Miguel
[Spinal cord compression as the presenting form of non-Hodgkin's lymphoma].
Sangre 1995;40(6):505-7.
1995: Luis Escribano; Alberto Orfao; Jesus Villarrubia; C Cerveró; JL Velasco; F Martín; Jesús F San Miguel; José L Navarro
Expression of lymphoid-associated antigens in mast cells: report of a case of systemic mast cell disease.
British journal of haematology 1995;91(4):941-3.
1995: Ana Macedo; Alberto Orfao; Juana Ciudad; M Gonzalez; Belén Vidriales; Maria-Consuelo Lopez-Berges; A Martínez; C Landolfi; C Cañizo; Jesús F San Miguel
Phenotypic analysis of CD34 subpopulations in normal human bone marrow and its application for the detection of minimal residual disease.
Leukemia 1995;9(11):1896-901.
1995: Julia Almeida; María Antonia García-Marcos; Carlos Vallejo; M T Flores; María Dolores Caballero; Jesús F San Miguel; A Ríos
[Results of a series of 104 consecutive bilateral bone marrow biopsy specimens in lymphoproliferative disorders].
Sangre 1995;40(5):365-8.
1995: María Dolores Tabernero; Jesús F San Miguel; Juan Luis Garcia; M Garcia-Isidoro; J Wiegant; Juana Ciudad; M Gonzalez; A Rios; A Raap; Alberto Orfao
Clinical, biological, and immunophenotypical characteristics of B-cell chronic lymphocytic leukemia with trisomy 12 by fluorescence in situ hybridization.
Cytometry 1995;22(3):217-22.
1995: A Macedo; Alberto Orfão; M Gonzalez; María-Belén Vidriales; Ma Consuelo López-Berges; A Martínez; Jesús F San Miguel
Immunological detection of blast cell subpopulations in acute myeloblastic leukemia at diagnosis: implications for minimal residual disease studies.
Leukemia 1995;9(6):993-8.
1995: Julia Almeida; Consuelo del Cañizo; Alberto Orfao; J Hernandez; D Hernandez; Josefina Galende; Dolores Caballero; R Garcia-Sanz; Jesús F San Miguel
In vitro autonomous proliferation in ANLL: clinical and biological significance.
Leukemia research 1995;19(6):411-6.
1995: María-Belén Vidriales; Alberto Orfao; Ma Consuelo López-Berges; Marcos González; A López-Macedo; M A García; J Galende; Jesús F San Miguel
Light scatter characteristics of blast cells in acute myeloid leukaemia: association with morphology and immunophenotype.
Journal of clinical pathology 1995;48(5):456-62.
1995: María-Belén Vidriales; Alberto Orfao; Ma Consuelo López-Berges; Marcos González; A López-Macedo; Juana Ciudad; Antonio López; MC Cañizo; M A Garcia; Jesús F San Miguel
DNA aneuploidy in acute myeloblastic leukemia is associated with a high expression of lymphoid markers.
Cytometry 1995;22(1):22-5.
1995: C Iglesias-Osma; L Gonzalez-Villaron; Jesús F San Miguel; María Dolores Caballero; Lourdes Vazquez; S de Castro
Iron metabolism and fungal infections in patients with haematological malignancies.
Journal of clinical pathology 1995;48(3):223-5.
1995: Ana Macedo; Alberto Orfao; A Martínez; María-Belén Vidriales; B Valverde; Ma Consuelo López-Berges; Jesús F San Miguel
Immunophenotype of c-kit cells in normal human bone marrow: implications for the detection of minimal residual disease in AML.
British journal of haematology 1995;89(2):338-41.
1995: Jesús F San Miguel; Ramón García-Sanz; Marcos González; María Jesús Moro; Jesús M Hernández; F Ortega; D Borrego; M Carnero; F Casanova; R Jiménez
A new staging system for multiple myeloma based on the number of S-phase plasma cells.
Blood 1995;85(2):448-55.
1995: Alberto Orfao; Juana Ciudad; M Gonzalez; A Lopez; M del Mar Abad; J I Paz Bouza; Juan J Cruz; Alberto Gomez-Alonso; Jesús F San Miguel
Flow cytometry in the diagnosis of cancer.
Scandinavian journal of clinical and laboratory investigation. Supplementum 1995;221():145-52.
1995: I Sánchez; Jesús F San Miguel; J Corral; C Martín; R Pérez; Marcos González; MC Cañizo; Alberto Orfao; Rogelio González-Sarmiento
Gene rearrangement in acute non-lymphoblastic leukaemia: correlation with morphological and immunophenotypic characteristics of blast cells.
British journal of haematology 1995;89(1):104-9.
1994: A Orfäo; Ramón García-Sanz; Ma Consuelo López-Berges; M Belén Vidriales; Marcos González; María Dolores Caballero; Jesús F San Miguel
A new method for the analysis of plasma cell DNA content in multiple myeloma samples using a CD38/propidium iodide double staining technique.
Cytometry 1994;17(4):332-9.
1994: Josefina Galende; M L Vazquez; Julia Almeida; M C Peña Penabad; E Fernandez Lopez; María Dolores Caballero; Jesús F San Miguel
Histiocytic cytophagic panniculitis: a rare late complication of allogeneic bone marrow transplantation.
Bone marrow transplantation 1994;14(4):637-9.
1994: Julia Almeida; Maria Consuelo Del Cañizo; Josefina Galende; Belén Vidriales; Maria J Nieto; M D Hernández; M J Rodríguez; Jesús F San Miguel
[Clonogenic cells of acute leukemia secondary to myeloproliferative and myelodysplastic syndromes].
Sangre 1994;39(5):331-5.
1994: Ana Macedo; Alberto Orfao; Juana Ciudad; Jesús F San Miguel
[Phenotypic characterization of normal myeloid differentiation].
Sangre 1994;39(4):277-82.
1994: Maria Consuelo Del Cañizo; Julia Almeida; Jesús F San Miguel; Alberto Orfao; M Gonzalez; A Lopez Borrasca
The phenotype of L-CFU and its correlation with the immunological characteristics of the blast cell population in AML.
Annals of hematology 1994;68(5):233-6.
1994: Ramón García-Sanz; Ignacio Alberca; Lourdes Vázquez; Jesús M Hernández; Agustin Castellanos; Jesús F San Miguel
[Control of oral anticoagulant treatment using an automated method].
Sangre 1994;39(2):95-8.
1994: Alberto Orfao; Juana Ciudad; Maria-Consuelo Lopez-Berges; A Lopez; Belén Vidriales; María Dolores Caballero; B Valverde; M Gonzalez; Jesús F San Miguel
Acute lymphoblastic leukemia (ALL): detection of minimal residual disease (MRD) at flow cytometry.
Leukemia & lymphoma 1994;13 Suppl 1():87-90.
1993: R García; Jesús M Hernández; María Dolores Caballero; M González; Josefina Galende; Maria Consuelo Del Cañizo; Lourdes Vázquez; Jesús F San Miguel
Serum lactate dehydrogenase level as a prognostic factor in Hodgkin's disease.
British journal of cancer 1993;68(6):1227-31.
1993: María-Belén Vidriales; Alberto Orfao; Ma Consuelo López-Berges; Marcos González; J M Hernandez; Juana Ciudad; Antonio López; María Jesús Moro; M Martínez; Jesús F San Miguel
Lymphoid subsets in acute myeloid leukemias: increased number of cells with NK phenotype and normal T-cell distribution.
Annals of hematology 1993;67(5):217-22.
1993: J M Hernández; I Sánchez; Marcos González; Alberto Orfao; Rogelio González-Sarmiento; Jesús F San Miguel
Acute lymphoid leukemias following either a previous chronic myelogenous leukemia or myelodysplastic syndrome: phenotypic and genomic differences.
American journal of hematology 1993;43(4):256-8.
1993: Joan Bladé; Jesús F San Miguel; A Alcalá; J Maldonado; Miguel A Sanz; Javier García Conde; M J Moro; C Alonso; Joan Besalduch; A Zubizarreta
Alternating combination VCMP/VBAP chemotherapy versus melphalan/prednisone in the treatment of multiple myeloma: a randomized multicentric study of 487 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(6):1165-71.
1993: Jesús F San Miguel; Jesus M Hernandez; R Gonzalez; M Gonzalez; I Sanchez; Alberto Orfao; Maria Consuelo Del Cañizo; A Lopez-Borrasca
Multiparameter analysis of blast cells in patients with acute leukemia following a primary myelodysplastic syndrome.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;131():393-400.
1993: Alberto Orfao; Belén Vidriales; M Gonzalez; Maria-Consuelo Lopez-Berges; Maria Consuelo Del Cañizo; Jesús F San Miguel
Diagnostic and prognostic importance of immunophenotyping in adults with acute myeloid leukemia.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;131():369-79.
1992: Guillermo J Ruiz-Argüelles; Eduardo Lobato-Mendizábal; Jesús F San Miguel; M González; María Dolores Caballero; Alejandro Ruiz-Argüelles; Alberto Orfao; David Gómez-Almaguer; Belén Vidriales; G Ruiz-Reyes
Long-term treatment results for acute megakaryoblastic leukaemia patients: a multicentre study.
British journal of haematology 1992;82(4):671-5.
1992: María Dolores Caballero; Marcos González; MC Cañizo; Alberto Orfao; Maria J Nieto; Jesús F San Miguel
Concomitant chronic lymphocytic leukemia (CLL) and acute myeloid leukemia. Complete remission of CLL achieved with high-dose cytosine arabinoside.
Leukemia 1992;6(8):856-8.
1992: J M Hernández; Jesús F San Miguel; Marcos González; Alberto Orfao; MC Cañizo; C Bascones; J Hernández; A López Borrasca
Development of acute leukaemia after idiopathic myelofibrosis.
Journal of clinical pathology 1992;45(5):427-30.
1992: Jesús F San Miguel; Marcos González; Alicia R Gascón; María Jesús Moro; Jesús M Hernández; F Ortega; R Jiménez; L Guerras; M Romero; F Casanova
Lymphoid subsets and prognostic factors in multiple myeloma. Cooperative Group for the Study of Monoclonal Gammopathies.
British journal of haematology 1992;80(3):305-9.
1992: M Gonzalez; Jesús F San Miguel; A Gascon; María Jesús Moro; J M Hernandez; F Ortega; R Jimenez; L Guerras; M Romero; F Casanova
Increased expression of natural-killer-associated and activation antigens in multiple myeloma.
American journal of hematology 1992;39(2):84-9.
1992: Alberto Orfao; Juana Ciudad; Marcos González; Jesús F San Miguel; A R García; Ma Consuelo López-Berges; F Ramos; Maria Consuelo Del Cañizo; A Ríos; M Sanz
Prognostic value of S-phase white blood cell count in B-cell chronic lymphocytic leukemia.
Leukemia 1992;6(1):47-51.
1991: J M Hernández; Rogelio González-Sarmiento; C Martin; Marcos González; I Sánchez; J Corral; Alberto Orfao; MC Cañizo; Jesús F San Miguel; A López-Borrasca
Immunophenotypic, genomic and clinical characteristics of blast crisis of chronic myelogenous leukaemia.
British journal of haematology 1991;79(3):408-14.
1991: Jesús M Hernández; Jesús F San Miguel; Marcos González; José María Moraleda; María Jesús Moro; José Hernández; B Cuesta; A López Borrasca
[Clinico-hematological characteristics of acute transformation of chronic myeloproliferative syndromes].
Medicina clínica 1991;97(10):369-72.
1991: E Gómez; Jesús F San Miguel; M González; Alberto Orfao; Consuelo López-Berges; A Ríos; A López Borrasca
Heterogeneity of T cell lymphoblastic leukaemias.
Journal of clinical pathology 1991;44(8):628-31.
1991: Jesús F San Miguel; J M Hernández; Rogelio González-Sarmiento; Marcos González; I Sánchez; Alberto Orfao; MC Cañizo; A López Borrasca
Acute leukemia after a primary myelodysplastic syndrome: immunophenotypic, genotypic, and clinical characteristics.
Blood 1991;78(3):768-74.
1991: E Gómez; Jesús F San Miguel; Marcos González; Alberto Orfao; MC Cañizo; Juana Ciudad; A López Borrasca
[Phenotypic changes in refractory and relapse acute lymphoblastic leukemias].
Sangre 1991;36(3):201-4.
1991: Jesús F San Miguel; Marcos González; Alicia R Gascón; María Jesús Moro; Jesús M Hernández; F Ortega; R Jimenez; L Guerras; M Romero; F Casanova
Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease. Castellano-Leones (Spain) Cooperative Group for the Study of Monoclonal Gammopathies.
British journal of haematology 1991;77(2):185-90.
1991: Jesús F San Miguel; M Moro; J Bladé; L Guerras; J Hernandez; R Jiminez-Galindo; F Ortega; M Gonzalez
Interferon and dexamethasone in multiple myeloma patients refractory to chemotherapy.
European journal of cancer (Oxford, England : 1990) 1991;27 Suppl 4():S48-9.
1990: Jesús F San Miguel; M Moro; J Bladé; L Guerras; J Hernandez; R Jimenez-Galindo; F Ortega; M Gonzalez
Combination of interferon and dexamethasone in refractory multiple myeloma.
Hematological oncology 1990;8(4):185-9.
1990: A Ríos; MC Cañizo; M A Sanz; T Vallespí; G Sanz; Marta Torrabadella; Federico Gomis; C Ruiz; Jesús F San Miguel
Bone marrow biopsy in myelodysplastic syndromes: morphological characteristics and contribution to the study of prognostic factors.
British journal of haematology 1990;75(1):26-33.
1990: Maria Consuelo Del Cañizo; Julia Almeida; Jesús F San Miguel
[The clonogenic cell in acute myeloblastic leukemia].
Sangre 1990;35(2):125-7.
1990: Alberto Orfao; M Gonzalez; Jesús F San Miguel; J F Tomas; M C Canizo; M C Lopez-Berges; José María Moraleda; A Lopez Borrasca
Surface phenotype and immunoglobulin levels in B-cell chronic lymphocytic leukaemia.
Haematologia 1990;23(1):49-56.
1989: Julia Almeida; C Cañizo; I J Sánchez; Maria J Nieto; Jesús F San Miguel; Marcos González; Alberto Orfao
[Study of leukemic colony-forming units (CFU-L) in non-lymphoblastic malignant hemopathies].
Sangre 1989;34(6):467-70.
1989: Guillermo F Sanz; Miguel A Sanz; T Vallespí; MC Cañizo; Marta Torrabadella; S García; D Irriguible; Jesús F San Miguel
Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients.
Blood 1989;74(1):395-408.
1989: M C del Cañizo; Guillermo Sanz; Jesús F San Miguel; T Vallespi; D Irriguible; Marta Torrabadella; Miguel A Sanz
Chronic myelomonocytic leukemia--clinicobiological characteristics: a multivariate analysis in a series of 70 cases.
European journal of haematology 1989;42(5):466-73.
1989: Jesús F San Miguel; EMILIO OJEDA; M Gonzalez; Alberto Orfao; MC Cañizo; J Sanchez; A Lopez-Borrasca
Prognostic value of immunological markers in acute myeloblastic leukemia.
Leukemia 1989;3(2):108-11.
1989: Guillermo F Sanz; Miguel A Sanz; T Vallespí; MC Cañizo; S García; Marta Torrabadella; Jesús F San Miguel; D Irriguible
[Prediction of survival in myelodysplastic syndrome. Analysis of 2 scoring systems with prognostic value].
Sangre 1989;34(1):41-6.
1988: Jesús F San Miguel; José F Tomás; M J Martín; A Ríos; José María Moraleda; MC Cañizo; Marcos González; Maria J Nieto; J Sánchez; A López Borrasca
[Non-Hodgkin's lymphomas. II. Prognostic factors].
Sangre 1988;33(5):367-71.
1988: José F Tomás; Jesús F San Miguel; M J Martín; R Martínez; José María Moraleda; Marcos González; MC Cañizo; EMILIO OJEDA; F Ramos; T Flores
[Non-Hodgkin's lymphomas. I. Clinico-biological features in a series of 98 patients].
Sangre 1988;33(5):361-6.
1988: Alberto Orfao; Marcos González; Jesús F San Miguel; Mercedes Corral; Maria J Nieto; MC Cañizo; J Hernández; J Fernández Calvo; A López Borrasca
[Chronic B-cell lymphatic leukemia: autoimmune hemolytic anemias versus anemias caused by marrow failure].
Sangre 1988;33(4):296-300.
1988: EMILIO OJEDA; Jesús F San Miguel; M González; C Cañizo; Alberto Orfao; A Ríos; A López-Borrasca
[Comparative study of the FAB classification and an immunologic classification model for the acute myeloid leukemias].
Sangre 1988;33(4):291-5.
1988: Jesús F San Miguel; M Gonzalez; MC Cañizo; EMILIO OJEDA; Alberto Orfao; María Dolores Caballero; María Jesús Moro; P Fisac; A Lopez Borrasca
Leukemias with megakaryoblastic involvement: clinical, hematologic, and immunologic characteristics.
Blood 1988;72(2):402-7.
1988: Maria Consuelo Del Cañizo; EMILIO OJEDA; Jesús F San Miguel; A Brufau; M González; Alberto Orfao; A Ríos; A López Borrasca
[Effect of a leukocyte medium conditioned with PHA on the proliferation and differentiation of leukemic cells].
Sangre 1988;33(1):15-9.
1988: Alberto Orfao; M Gonzalez; Jesús F San Miguel; MC Cañizo; P Galindo; María Dolores Caballero; R Jimenez; A Lopez Borrasca
Clinical and immunological findings in large B-cell chronic lymphocytic leukemia.
Clinical immunology and immunopathology 1988;46(2):177-85.
1987: M C del Canizo; Jesús F San Miguel; M Gonzalez; J P Anta; A Orfao; A Lopez-Borrasca
Discrepancies between morphologic, cytochemical, and immunologic characteristics in acute myeloblastic leukemia.
American journal of clinical pathology 1987;88(1):38-42.
1987: M Gonzalez; Jesús F San Miguel; J P Anta; EMILIO OJEDA; A Lopez-Borrasca
Cell lineage switches in blast crisis of a Ph1 positive chronic granulocytic leukemia.
Haematologica 1987;72(3):249-51.
1987: Maria Consuelo Del Cañizo; Jesús F San Miguel; A Gascón; A Rios; José María Moraleda; M González; J P Anta; J Sánchez; A López Borrasca
[Myelodysplastic syndromes: characterization of a series of 56 patients classified according to FAB criteria].
Sangre 1987;32(4):436-44.
1987: Alberto Orfao; M Gonzalez; Jesús F San Miguel; María Jesús Moro; J Fernandez-Calvo; M Carnero; P Galindo; A Lopez Borrasca
Surface phenotype and clinical stages in B-cell chronic lymphocytic leukaemia.
Haematologica 1987;72(1):39-43.
1986: Jesús F San Miguel; M Gonzalez; MC Cañizo; J P Anta; H Zola; A Lopez Borrasca
Surface marker analysis in acute myeloid leukaemia and correlation with FAB classification.
British journal of haematology 1986;64(3):547-60.
1986: José María Moraleda; R Gonzalez; Adrián Alegre; J P Anta; Jesús F San Miguel
Bone marrow necrosis and treatment with interferon.
Journal of clinical pathology 1986;39(9):1045.
1986: Jesús F San Miguel; M González; MC Cañizo; J P Anta; J A Portero; A López-Borrasca
TdT activity in acute myeloid leukemias defined by monoclonal antibodies.
American journal of hematology 1986;23(1):9-17.
1986: Jesús F San Miguel; M González; MC Cañizo; J P Anta; J Hernández; F Ortega; L Borrasca
The nature of blast cells in myelodysplastic syndromes evolving to acute leukaemia.
Blut 1986;52(6):357-63.
1986: Alberto Orfao; M González; Jesús F San Miguel; P Galindo; María Jesús Moro; R Jiménez Galindo; C Bascones; A López Borrasca
[Clinico-pathological features and clinical stages in chronic lymphatic leukemia. Multivariate analysis].
Sangre 1986;31(5):550-8.
1985: Jesús F San Miguel; M González; MC Cañizo; J P Anta; José María Moraleda; A Ríos; María Dolores Caballero; F Ortega; A López Borrasca
[The megakaryoblastic component of mixed blast crises].
Sangre 1985;30(3):330-6.
1984: Jesús F San Miguel; M González; María Dolores Caballero; A Ríos; T Santoro; H Zola; A López Borrasca
[Immunologic characterization of hairy-cell leukemia or tricholeukemia].
Sangre 1984;29(3):280-6.
1983: Maria Consuelo Del Cañizo; Jesús F San Miguel; María Dolores Caballero; M González; A Ríos
[Cytochemistry of tricholeukemia].
Sangre 1983;28(6):794-5.
1983: Jesús F San Miguel; J A Portero; M Gonzaĺez; J P Plaza; M D Caballero; A De Cecilia; J J Fernández; A López Borrasca
[The importance of terminal deoxyribonucleotidyl transferase in myeloblastic leukemias. Apropos of 2 cases].
Sangre 1983;28(6):746-52.